An investigation of the evolution of the anguimorph lizard venom system by Koludarov, Ivan
  
 
 
An investigation of the evolution of the anguimorph lizard venom 
system 
Ivan Koludarov 
BSc (Biology); MSc (Biology) 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2016 
School of Biological Sciences 
 2 
Abstract 
Over the course of the last two decades significant advances were made in our 
understanding of the evolution of venom in squamate reptiles. Several studies looked at 
nuclear genes from various lizards and snakes and confirmed the hypothesis put forth in 
E. Kochva’s article “Phylogeny of the oral glands in reptiles as related to the origin and 
evolution of snakes” – that anguimorph lizards form part of a monophyletic clade with all 
the snakes. This confirmation confounded decades of morphology based taxonomy, as did 
evidence of the inclusion of the Iguania lizard lineage into that group. The new group 
received the name Toxicofera, emphasizing the role of oral toxins in the evolution of the 
lineage. Despite being supported by genetic, anatomical and proteomic data, the 
Toxicofera hypothesis remains controversial. This strengthens the necessity for thorough 
investigation of toxicoferan reptile venom evolution. The oral secretions of anguimorph 
lizards demand particular attention not only because they are understudied, but also for 
the reason that Anguimorpha contains species with the considerable morphological 
diversity of venom glands – from incipient to advanced and almost snake-like. 
 
Therefore the primary goal of this thesis is to address the lack of knowledge on 
anguimorph lizard oral secretions, in particular that of varanoid lizards which include 
various monitor species (genus Varanus) as well as Heloderma (gila monster) and 
Lanthanotus (Borneo earless monitor). This has been achieved through the 
implementation of several proteomic techniques (in particular, gel electrophoresis) as well 
as transcriptomic analysis and bioactivity testings. 
 
Chapter One reviews all previously published information on anguimorph venom evolution, 
highlighting the data in support of the Toxicofera hypothesis. Chapter Two presents new 
data on Heloderma lizard venoms and the striking similarities between the venom profiles 
of specimens from different localities as well as between species. The data presented and 
discussed in Chapter Three represents the core finding of this study: the surprising 
complexity and diversity of varanid lizard oral secretions.  
 
Taken together, this study present a compelling argument in favour of functional diversity 
and differential complexity of the venom of anguimorph lizards and discusses the 
evolutionary forces that helped generate this diversity. 
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Introduction 
After being neglected for a long period of time the field of lizard venomics has made 
significant progress in the 21 century. It is now an established fact that the oral glands of 
an array of Anguimorpha lizards (amongst others containing monitor lizards and beaded 
lizards) produce a complex mix of toxins, including toxins of families previously known only 
from snake venom. 
Together with Iguania and Serpentes, Anguimorpha form the monophyletic clade 
Toxicofera, the common ancestor of which possessed oral glands that acted as the 
substrate for evolution of all known venom systems in reptiles. Several “core” (putatively 
ancestral) toxicoferan reptile toxin groups have been revealed, with homologs recovered 
from oral glands all across the clade. 
Anguimorpha is a diverse group of lizards that contains several major lineages, of which 
helodermatid and varanid lizards are of special interest for modern venomics, as they 
provide an example, parallel to that of snakes, of the evolution of complex oral secretions 
and thus allow for evolutionary hypotheses to be formed based on differences and 
similarities in their venom systems. 
Of all the anguimorph lizards, complex oral glands are found only amongst beaded lizards 
(Heloderma), and monitors (Varanus and Lanthanotus), with other species having 
relatively simple glands. This complexity evolved independently in the two lineages of 
venomous lizard. In both cases oral glands are covered by a thick membrane and have a 
structured lumen. 
Chapter 1 discusses the Anguimorpha venom system in detail and reviews all the relevant 
information published prior to this thesis. The protein classes known or suspected to be 
present in anguimorpha lizard venoms are discussed with sufficient detail to provide the 
reader with the background information that subsequent chapters are built upon. 
Chapter 2 presents a published proteomic study of Heloderma venom. Though 
helodermatid lizards have previously received significantly more attention than any other 
anguimorph lizard, including drug development research, our understanding of their venom 
is far from complete. The role of the venom in their evolutionary history and the extent to 
which they deploy it in their feeding or defense remains enigmatic. In our study we aimed 
 11 
to breach some of this gap and conjectured evolutionary forces that may have shaped the 
extant Heloderma venom system. 
On the other hand, venom in varanid lizards remains largely unstudied and some 
researchers remain skeptical as to whether varanid oral secretions possess any significant 
toxic activity despite the growing amount of evidence suggesting otherwise. Our study of 
this unique venom system is summarised in Chapter 3 that concludes the thesis. 
All extant monitor lizards other than Lanthanotus borneensis belong to the Varanus genus. 
Their recent radiation in Australia resulted in great diversity of body size, ranging from 20 
cm for dwarf monitor (V. brevicauda) to 3 m for Komodo Dragon, making the genus the 
most variable in body size of all extant vertebrate animals (except snakes). This diversity is 
even greater once the recently extinct 7m Varanus (Megalania) prisca is taken into 
consideration (Ast, 2001; Pianka and King, 2004). This diversity of form corresponds to 
diversity in habitat and diet: terrestrial monitors are large, while rock-dwelling lizards are 
small, with aquatic and arboreal species being somewhere in-between and 
morphologically specialised in their own ways. 
To date no study has looked into the relationship between habitat, diet and venom 
composition in varanid lizards. Such a study will immensely contribute to our 
understanding of evolution of venom in reptiles as well as helping us to build a bigger 
picture of the evolution of venom in the animal kingdom. 
Apart from tracing an evolutionary history, the study of monitor lizard oral secretions can 
lead to a drug discovery, since some of the toxins are exclusive to this lineage. A similar 
approach led to the discovery of exendin, found to be a peptide agonist of the glucagon-
like peptide (GLP) receptor that promotes insulin secretion. It has been clinically used to 
treat type 2 diabetes and to enhance plasma insulin secretion. 
Implementing an array of proteomic and transcriptomic methods, the present thesis aims 
to significantly increase the available data on venom complexity and content in 
Anguimorpha as well as to shed light on the evolutionary forces that shape them. 
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Chapter 1. Lizards: more than venomous. A review 
of past studies on Anguimorpha venom system.  
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Lizards: more than venomous. A review of past studies on 
Anguimorpha venom system. 
Abstract 
Venom research in reptiles is mostly focused on medically important front-fanged snakes 
that significantly contribute to animal-facilitated mortalities in humans. This is one of the 
reasons why venomous organisms that do not present an immediate threat to human 
health are severely understudied. However, improving our understanding of the role 
venom plays in non-medically important species could not only dramatically improve our 
understanding of venom and toxin evolution but may also lead to advances in drug design. 
This review puts together several decades worth of research on Anguimorph lizard venom 
systems in an attempt to demonstrate the sophistication and complexity of lizard venoms. 
At the same time it aims to show that the extent of current knowledge on the topic is only 
the tip of the iceberg, and future research is needed to fully uncover the properties and 
functions of lizard toxins, with all indicators pointing to the possibility of the high medicinal 
impact such research can foster. 
Toxicofera 
Until the beginning of the 21st century members of the genus Heloderma, most importantly 
the iconic gila monster, were considered to be the only venomous lizards. However, the 
recent expansion of scientific knowledge on the evolution of venom in reptiles as well as 
on the nature of oral glands in helodermatid lizards and their relatives revealed that reality 
is considerably more complicated. 
Recent studies demonstrated that all members of the lizard clade Anguimorpha possess 
oral glands homologous to the venom glands of the front-fanged snakes (Vidal and 
Hedges, 2005; 2009; Fry et al., 2006; 2009b; 2010b). In addition, these studies 
demonstrated that all venomous lizards and all snakes share a common ancestor that may 
have possessed an incipient venom system, and that any modern day snakes lacking 
venom do so as the result of secondary loss. 
This discovery was built upon two higher-level genetic studies aimed to solve phylogenetic 
conflicts within Squamata (Vidal and Hedges, 2004; Townsend et al., 2004). These studies 
suggested that previous morphology-based phylogenetic relationships are incorrect in 
positionining Iguania as a sister group to the rest of squamates. 
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Investigations shortly thereafter resolved aspects of the higher order relationships, finding 
snakes formed a clade with the two lizard lineages Anguimorpha and Iguania, and that the 
common ancestor of the clade lived some 170 million years ago. Based on the clade’s 
principle synapomoprhy, toxin-secreting oral glands, this ancestor likely had oral secretory 
apparatus that acted as the basis for the subsequent evolution of venom systems in the 
Anguimorpha and Serpentes (Fry et al., 2006; Vidal and Hedges, 2005). The name 
Toxicofera was given in order to reflect the role venom played in the evolution of the clade. 
Subsequent studies utilising a growing number of sampled taxa further corroborated the 
monophyletic origin of the Toxicofera and attempted to clarify relationships within it (e.g., 
Pyron et al., 2013, Reeder et al., 2015). The study by Reeder et al. compared molecular, 
morphological and fossil data and suggested that the perceived discordance between 
squamate phylogenies based on morphological and genetic data is largely due to inability 
of the former to discern between the multiple origins of limblesness in reptiles. If 
appropriately corrected, the morphological data is in fact concordant with the results drawn 
from molecular data. The study also placed Mosasauria and Polyglyphanodontia in 
Toxicofera as sister groups to Serpents (Reeder et al., 2015). A recent study (Hsiang et 
al., 2015) produced trees that were skewed by the inclusion of genetics, morphology and 
fossils (with the last two not always being present for a particular extant lineage). Hsiang et 
al. based their preferred tree on combined molecular and phenotypic data, but with many 
relationships constrained to match the phenotype-based tree, which was weakly 
supported. Since addressing it is beyond the scope of this chapter please refer to Streicher 
and Wiens for detailed discussion (Streicher and Weins, 2016). Thus recent reviews that 
relied on the Hsiang et al trees to reconstruct the evolutionary history of the organisms and 
also the associated venom systems inherit the problems of the original study (Mackessy et 
al., 2016; Sweet, 2016). Both Mackessy and Sweet also relied heavily upon Hargreaves 
tissue expression paper (Hargreaves et al., 2014) for their interpretation. For the exact 
differences between the traditional and Toxicofera phylogenetic approaches we 
recommend looking into dedicated studies (Streicher and Weins, 2016; Mackessy et al., 
2016; Reeder et al., 2015; Jackson et al., 2016; Zheng and Weins, 2016; Vidal and 
Hedges, 2009; Townsend et al., 2004). 
One of the major implications of the Toxicofera grouping in respect to the present study is 
that the presence of any venomous lizards outside of this clade is unlikely (though 
obviously not impossible) since the oral secretory apparatus that gave rise to all the known 
types of venom systems in reptiles is hypothesised to have evolved once within the clade. 
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Such a consideration does not, however, deplete the scope of possibilities considering that 
fossil evidence suggests that venom also evolved within the Sphenodontidae family during 
the Jurassic period (Reynoso, 2005). This putatively venomous squamate belongs to a 
family of which the only current extant representatives are the non-venomous New 
Zealand tuataras. However, in the absence of evidence for any other extant venomous 
lineage, the Toxicofera grouping also implies that any biodiscovery search for venom-
derived components with a potential for therapeutic use should be focused on the 
unstudied members of the clade as they represent an untapped natural resource. 
Evolution of the venom system in reptiles 
The proposed ancestor of the Toxicofera clade had relatively simple serous dental glands 
in both upper and lower jaws (Fry et al., 2006), with the protein-secreting region being 
enlarged and distinct from the smaller mucus-secreting parts. These glands produced 
active substances that became the substrate for the evolution of all known reptilian toxins. 
For detailed discussion on types and evolution of reptile venom glands see “Endless forms 
most beautiful: the evolution of ophidian oral glands, including the venom system, and the 
use of appropriate terminology for homologous structures” (Jackson et al., 2016). 
Iguania split off while this system was still developing and in most iguanian species the 
glands remain in the plesiomorphic state. The apparent lack of specialisation or refinement 
of the venom system within the Iguania is likely due to the fact that most species are 
insectivorous or herbivorous. However, toxin genes continue to be expressed in the venom 
glands of these lizard. It is also worth mentioning that bearded dragons and frilled dragons 
possess considerably larger glands than insectivorous and herbivorous species (Fry et al., 
2006, 2013).  
In contrast with iguanian lizards, venom became of greater importance within both the 
snakes and anguimorph lizards via differential evolutionary trajectories. Despite sharing a 
common origin, both groups have developed unique venom systems, presumably in 
accordance with differences in the evolutionary history and ecological role of venom 
between the two. In snakes the glands on the upper jaw became extensively diversified, 
while the lower jaw glands are atrophied or missing entirely in most species (Fry et al., 
2006). However, some species of snakes do have active mandibular toxin-secreting 
glands (Fry, 2015). 
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On the other hand, the evolution of oral secretory apparatuses in anguimorph lizards 
resulted in extensive diversification of the glands on the lower jaw, with a correspondent 
regression of the maxillary glands, which are absent in most of the modern species studied 
(Fry et al., 2010b). The only anguimorph lizard currently known to retain maxillary glands 
in addition to mandibular glands is Pseudopus apodus (European legless lizard) (Fry et al., 
2010b). 
It has to be noted that both within snakes and anguimorph lizards there are differences in 
the location and types of secretory epithelia, as well as in the number and physical 
orientation of the gland compartments and the degree of encapsulation of the glands (Fry 
et al., 2006, 2010b), which strengthens the idea that venom system in reptiles exist in a 
continuum of forms and functions (Jackson et al., 2016).  
Unlike the relatively simple venom glands of other anguimorph lizards, Heloderma and 
Varanus venom glands have independently evolved into complex organs with segregated 
protein and mucous secreting regions (Fry et al., 2010a,b). In both cases the glands are 
encapsulated by a thick membrane and have a reduced number of compartments, which 
are fused to increase storage space of the highly structured lumen (Russel and Bogert, 
1981; Fry et al., 2006, 2010a,b).  
The homology of lizard and snake venom glands was further corroborated by the data on 
expression of shared toxin genes. Several types of proteins were found to be expressed in 
the venom glands of both snakes and lizards: AVIT, CRiSP, kallikrein, nerve growth factor 
(Fry et al., 2006), hyaluronidase (Fry et al., 2010b) and kunitz peptides (Koludarov et al., 
2012).  
The complexity of varanid lizard oral gland transcriptomes is comparable to those of other 
reptile venom glands, containing a range of potentially active components: natriuretic 
peptides, type III PLA2, CRiSP and kallikrein (Fry et al., 2010b). Phospholipase A2 purified 
from varanid lizard venom causes platelet aggregation (Fry et al., 2006) – similar to the  
activity of PLA2 from Heloderma (Huang and Chiang, 1994). Intravenous injections of 
crude Varanus varius mandibular secretion to anaesthetized rats rapidly produced a sharp 
drop in blood pressure and specific analyses with precontracted rat aortic rings 
demonstrated relaxation of aortic smooth muscle, consistent with presence of natriuretic 
peptides in the venom and consistent with the testing of pure natriuretic peptides (Fry et 
al., 2006; 2009; 2010). Testing of other toxin types revealed a plethora of unique activities 
(Fry et al. 2010). 
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These data suggest that an ecological role of toxic oral secretions in lizards is not 
restricted to members of the Heloderma genus and might in fact be one of the evolutionary 
forces that shaped the Anguimorpha clade in a similar (though not as dramatic) way as in 
snakes. 
Anguimorpha 
The Anguimorpha clade has a Laurasian origin and currently includes slightly over 200 
extant species (Pianka and King, 2004; Vidal and Hedges, 2009) separated into two 
lineages each characterised by its geographical distribution. Paleoanguimorpha inhabit the 
Old World while Neoanguimorpha primarily inhabit the New World. The Neoanguimorpha 
includes Anguidae, Anniellidae, Diploglossidae, Helodermatidae and Xenosauridae; while 
Paleoanguimorpha includes Shinisauridae, Lanthanotidae and Varanidae (Vidal and 
Hedges, 2009). 
Heloderma 
There are five extant species of helodermatid lizards: H alvarezi, H. charlesbogerti, H. 
exasperatum, H. horridum (gila monster) and H. suspectum (beaded lizard) (Reiserer et 
al., 2013). All of which are native to the south-western regions of the North American 
continent. Helodermatid lizards are large (up to 550 mm for gila monster), relatively slow-
moving, largely nocturnal lizards. They are highly specialised for the rocky, semiarid 
habitat with scrub forestry that all of the species occupy. This is reflected in the extremely 
low-levels of morphological variation between the species. These lizards are also 
characterised by having a very low metabolic rate and showing a preference for low body 
temperatures, spending most of the year at temperatures lower than 25 °C. Helodermatid 
lizards are primarily nest feeders, raiding the nests of birds and mammals, but will readily 
kill and consume adult birds and rodents if they also happen to be in the nest (Pianka and 
King, 2004). 
Species that belong to the Heloderma genus have been recognised as venomous for more 
than a century, which is reflected in their Hispanic name “el scorpio” (Russel and Bogert, 
1981). Early accounts suggested the toxicity of gila monster venom to rattle snakes: “A 
lizard placed in a cage with a rattler shows no fear, and seems to recognize its superiority, 
while the snake, from the first, considers the monster a foe, and usually glides to the 
farthest corner of the cage. The lizard follows menacingly, and slowly moves up to the 
rattler until in a striking position. Then with a quick swing it imprisons the rattler's body in 
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its jaws and characteristically hangs on. The snake thrashes about, but seldom attempts to 
strike its deadly opponent. Three to five minutes are sufficient to quiet the average rattler 
and bring death, and then only does the victor loosen its grip on the snake's body. If the 
lizard battles an unusually large rattler, four and a half feet or over death may not result but 
for days the snake will appear very sick and almost lifeless” (Arrington, 1930). 
The teeth of helodermatid lizards are deeply grooved in a manner convergent with those of 
some advanced snakes, in which grooved, venom-delivering teeth have independently 
evolved on multiple occasions and display extensive variation  (Russel and Bogert, 1981; 
Fry et al., 2008), This is also convergent with various other extant and extinct venomous 
lineages including archosauriforms (Mitchell et al., 2010), conodonts (Szaniawski, 2009), 
sphenodons (Reyonso, 2005), insectivorous mammals such as shrews and solenodons 
(Cuenca-Bescos and Rofes, 2007; Dufton, 1992; Ligabue-Braun et al., 2012; Rofes and 
Cuenca-Bescos, 2009) and bird-like dinosaurs hypothesised to specialise in preying upon 
early birds (Gong et al., 2010). 
Helodermatid lizard venom glands are very large (Russel and Bogert, 1981). A recent MRI 
study showed that paired glands have six compartments with each compartment having its 
own duct that terminates at the base of the grooved teeth (Fry et al., 2010a). The glands 
are located in the anterior half of the lower jaw just beneath the skin, separated from the 
latter by the connective tissue. The glands can be noted by the swelling underlying the 
lower jaw. Each duct terminates on the outer side of certain teeth of the lower jaw and the 
venom is carried into the groove solely by capillary action. It can be further mixed with the 
saliva and thus be carried into the grooves of the upper teeth as well (Russel and Bogert, 
1981). 
Most of human envenomation by Heloderma involve lizards biting and holding with their 
strong jaws, sometimes for hours. Envenomation can result in complex symptoms such as 
extreme nausea, fever, myocardial infarction, tachycardia, hypotension and inhibition of 
blood coagulation as well as pain, acute local swelling and faintness (Preston, 1989; 
Strimple et al., 1997; Cantrell, 2003). No antivenom is required, and standard treatment is 
effective though severe pain may last for up to 12 hours (Hooker et al., 1994) and lack of 
response by the victim to non-steroidal anti-inflammatory analgesics might complicate the 
situation (Ariano-Sánchez 2008). 
Studies in mice found that subcutaneous injection of minimal lethal dose or similar 
amounts results in massive haemorrhages in the lungs, on the liver and intestinal organs, 
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on the epicardium, and especially in the various layers of the eyeball wall. Death occurred 
within 4-5 hours via pronounced asphyxia. In animals that were injected with higher doses, 
death occurred within 30-60 minutes without any observable haemorrhagic effect 
(Styblova and Karnalik, 1967). 
Extensive studies of helodermatid venom have revealed a great diversity of components. 
Kallikrein-like activity of the venom was first observed by Mebs (1968, 1969a, 1969b) and 
subsequently attributed to the kallikrein-like toxins helodermatine (Alagon et al., 1986) and 
gilatoxin (Utaisincharoen et al., 1993) that also possess fibrinolytic and haemorrhagic 
activity (Utaisincharoen et al., 1993; Datta and Tu, 1997; Nikai et al., 1988). Other potent 
components recovered include phospholipases A2 type III (Dehaye et al., 1984), 
helothermine (Mochca-Morales et al., 1990), helokinestatins (Kwok et al., 2008), 
helofensis with neurotoxic activity (Komori and Nikai, 1988) and exendin peptides (Parker 
et al., 1984). Of these, exendin-4, isolated from Heloderma suspectum venom was found 
to be a peptide agonist of the glucagon-like peptide (GLP) receptor that promotes insulin 
secretion. It has been clinically used to treat type 2 diabetes and to enhance plasma 
insulin secretion (Drucker and Nauck, 2006). 
Varanus 
All extant varanid lizards are members of the genus Varanus. These lizards are unique in 
their body size diversity, with a range from 23 cm (V. brevicauda) to over 3 m (V. 
komodoensis). The extinct species V. priscus (Megalania) is estimated to have reached 
between 6 and 9 m in total length, making the Varanus genus the most variable in body 
size of all extant vertebrate genera, with the sole exclusion of snakes (Sweet and Pianka, 
2007). Members of the genus have successfully colonised arboreal, terrestrial, rocky and 
aquatic habitats. Habitat preference is tightly linked with body size; body shape scales 
allometrically and otherwise is a subject of little to no change between the species 
(Openshaw and Keogh 2014, Clemente et al., 2013). Rock-dwelling varanids are usually 
small, whilst terrestrial and arboreal monitors are large and intermediate respectively 
(Collar et al., 2011). 
Of the more than 60 species worldwide, 5 occur in Africa and 7 are distributed across 
mainland southern Asia. 30 species, grouped into two distinct clades, occur on islands in 
Southeast Asia (four of those species are also present on the mainland). Species richness 
reaches its peak in Australia, with 29 named species (5 shared with New Guinea) 
belonging to the single Indo-Australian clade (Pianka and King, 2004; Ast, 2001). The 
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smaller Australian species like the members of the Odatria clade represent unique 
Australian derivations, as do the giants including the extinct V. prisca and the extant V. 
komodoensis. 
Most of the non-Australian varanids are large bulky lizards reaching more than 1.3 m in 
total length as adults. While the species diversity of large lizards does not change across 
Wallace’s line, the amount of small varanid lizard species increases sharply to the east of 
the line. This has been linked with the fact that Wallace’s line is a natural boundary for all 
small placental carnivores, such as cats, mustelids and viverrids. Apparently only large 
varanid species can coexist with placental carnivorous species, as they have big clutches 
and rapidly grow out of the vulnerable size range. Small varanid lizards always remain 
within the prey size range for carnivorous placental mammals that implement ambush 
hunting, unlike the Australian dasyurid marsupial carnivores that hunt by foraging (Sweet 
and Pianka, 2007). Consequently, of all the varanids lizards those in Australia have the 
most extreme variation in size and niche occupation. 
While all varanid lizards will predate upon literally anything they can overpower, each 
species has a unique range of prey items, with some being primarily insectivorous (V. 
gilleni), and some feeding on larger animals such as birds and mammals (V. giganteus) 
(Pianka and King, 2004).  
Similar to helodermatid lizards, monitors have large oral glands, homologous to those of 
front-fanged snakes. They also are divided into six compartments, even though the 
compartment structures are distinct from those of the helodermatids, and in varanids ducts 
terminate between successive bladelike teeth (Fry et al., 2010b). The helodermatid and 
varanid lineages thus represent independent derivations from the anguid lizard state, in 
which the protein and mucus secreting regions are divided and the protein secreting gland 
encapsulated to form a tube. The plesiomorphic anguimorph lizard state as seen in anguid 
lizards is characterised by the protein and mucus secreting cells being heterogenous, and 
presence of dorsal/ventral divisions within the gland lobules, with each lobule terminating 
between successive teeth along the jaw-line. 
The previous lack of sufficient knowledge of the role of venom in the Anguimorpha clade 
contributed to some misinterpretations of the feeding ecology of varanid lizards, in 
particular those of the iconic Varanus komodoensis (Komodo Dragon or ora). This species 
evolved in Australia around 4 million years ago but now can be found only on several 
Indonesian islands, mainly Komodo, Rinca, Flores, Gili Motang, and Gili Dasami (Hocknull 
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et al., 2009). The islands’ megafauna became extinct around 12,000 years ago, and for 
5,000 years V. komodoensis fed only on relatively small prey until the introduction, by 
humans, of pigs from Sulawesi. In recent history deer and water buffalo were also 
introduced on the islands, and now oras occupy a novel ecosystem, with their potential 
prey consisting of feral pigs, deer and buffalo. This situation has led to a unique ecological 
position for the Komodo Dragon, enabling it to function as an entire vertebrate predator 
guild, by going through rapid ontogenetic niche shifts from preying on relatively small 
arthropods as a juvenile to big ungulate mammals as an adult (Purwandana et al., 2016). 
V. komodoensis have light-weight skulls whose biting force is relatively weak compared to 
the mass of the animal (D’Amore et al., 2011; Moreno et al., 2008; Fry et al 2009). Instead 
of bite force, V. komodoensis utilise their large, serrated teeth as the primary weapon, 
inflicting deep parallel wounds in a ‘bite and slice’ form of a prey capture. Mechanical 
damage dealt to a prey may alone result in rapid death from blood loss, especially if major 
arteries are affected. 
While previously the long-lasting effects of ora’s bites were largely attributed to pathogenic 
bacteria this has since been suggested to be misleading as no pathogenic oral flora was 
recovered from V. komodoensis saliva or gingiva that would set it apart from any other 
carnivorous animal (Goldstein et al., 2013). While the effect might be attributed to the 
pathonogenic bacteria getting into the wound after the bite itself, that only seems plausible 
in case of attacked water buffalo that seek shelter in stagnant pools of water. Other prey 
animals do not display similar behaviour and their bite wounds do not exhibit the effects of 
pronounced sepsis like those of water buffalo. The overall clinical picture, including 
prolonged blood loss, suggests toxin action (Auffenberg, 1981), which is concordant with 
recent studies revealing that V. komodoensis venom contains anti-coagulant toxins that 
increase blood loss and other toxins that induce hypotension and shock (Fry et al., 2006, 
2009, 2010b). 
Though many bites by monitor lizards have been reported by the lay press, including a 
lethal attack of Komodo dragon on a 5-year old boy (Fry et al., 2010a), only a few cases of 
Varanus bites were published in peer-reviewed journals. A case of lethal bite attributed to 
V. bengalensis reports that a 55-year old female victim experienced severe local pain, 
blood loss, as well as nausea, diaphoresis, dizziness, and breathlessness (Vikrant and 
Verma, 2014). Though bleeding time was considered normal, the whole blood clotting time 
was prolonged. Patient was treated with injections of antihistaminic, hydrocortisone and 
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tetanus toxoid. 72h after the bite, patient succumbed to a sudden cardiac arrest. Post 
mortem kidney biopsy revealed that morphological features are consistent with acute 
tubular injury associated with pigment nephropathy. 
From the clinical picture and morphological features seen on kidney biopsy, authors 
concluded that this varanid lizard venom is capable of producing intravascular haemolysis, 
coagulopathy, and rhabdomyolysis. These pathogenic effects were responsible for causing 
the acute kidney injury. It was suggested that the direct nephrotoxicity of the lizard venom 
might have played a direct role, as it is known for other biological nephrotoxins (Strimple et 
al., 1997; Cantrell, 2003; Ariano-Sanchez, 2008; Piacentine et al., 1986; Preston 1989). 
The pathogenic mechanisms observed in the case were found very similar to those seen 
with snakebite-related acute kidney injury (Sitprija, 2006) and other authors have doubted 
the attribution to V. bengalensis, instead suggesting that the victim was bitten by a 
Russel’s viper (White and Weinstein, 2015). According to White and Weinstein, the 
vernacular name for V. bengalensis is ‘‘goh’’ (a contraction of ‘‘gohera’’ or ‘‘ghorpad’’) and 
is quite similar to ‘‘ghonas’’ and ‘‘gunas’’, local names for D. russelii. It has to be noted, 
that though initial effects such as prolonged blood loss, nausea and pain are consistent 
with the action of toxins recovered from varanid venom (Fry et al 2009), it remains to be 
elucidated whether varanid venom can cause acute kidney injury. 
In contrast, Ducey et al. report a much less dangerous bite by a juvenile Komodo dragon 
that resulted in a faintness, prolonged bleeding and transient hypotension (Ducey et al., 
2016). At 8 months postinjury, the victim still had tingling and numbness in the distal 
aspect of her right fifth finger where the tooth had been retained after the bite. Though 
authors admitted that there might be multiple reasons for the main hypotensive effect of 
the bite, they concluded that it was likely due to a vasovagal reaction – an autonomic 
nervous system response unspecific to the trigger – despite the effects being consistent 
with laboratory studies of Komodo dragon venom (Fry et al 2009). 
To date a number of toxin types have been recovered from varanid lizard oral secretions, 
most of them sharing type similarity with those recovered from helodermatid lizard 
venoms, reinforcing their shared evolutionary origin. Different forms of kallikrein toxins, 
CRiSP, natriuretic peptide, AVIT and phospholipases A2 reveal the ongoing evolution of 
varanid lizard venom systems, though few components have been functionally 
characterized (Fry et al., 2010b, 2013; Fry, 2015). 
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Other anguimorphs 
Most anguid lizards possess oral glands homologous to those of Heloderma and Varanus, 
though usually their glands are much less developed. Anguid lizard glands are usually of 
the mixed type, with a serous portion occupying the bottom of the gland and a mucous part 
above it, leading to the duct, which opens at the base of a tooth (Fry et al., 2010b). Of all 
the anguimorpha species studied to date, only Pseudopus apodus has retained the 
ancestral condition of having both maxillary and mandibular glands which have 
unstructured central lumens. In contrast, Lanthanotus borneensis – the closest extant 
relative of Varanidae – possesses serous protein-secreting glands with a well-structured 
lumen, encapsulated in a thick membrane in a similar manner to Varanus glands and thus 
also convergent with helodermatid lizard glands (Fry et al., 2010b).  
Though most of the anguimorph lizards are medically unimportant, they still secrete a 
number of plesiotypic toxicoferan toxin types. CRiSP and kallikrein are present in the 
venom gland transcriptomes of Pseudopus apodus, Gherronotus infernalis and Celestus 
warreni. The latter two species also share similar forms of helokinestatin and natriuretic 
peptides. Apart from that the three species have different toxin profiles: P. apodus 
expresses lectin, G. infernalis hyaluronidase, and C. warreni PLA2. C. warreni expresses a 
potential novel toxin type of its own – celestoxin, entirely unrelated to other Toxicofera or 
Anguimorpha toxins (Fry et al., 2010b).  
In our recent study of the venom gland trnascriptome of the small arboreal lizard Abronia 
graminea (Koludarov et al., 2012), we showed that members of Anguidae sometimes have 
robust and serous mandibular glands – traits usually considered reflective of a gland in 
active use. A wide array of recovered transcripts were shown to be homologous to those of 
helodermatid lizards, some of which are evidently under rapid diversification – in particular 
helokinestatin peptides. Interestingly, natriuretic peptides that are encoded in tandem with 
helokinestatins were shown to be largely under the influence of negative selection with 
27% of the sequence being under constraint. We were also able to sequence kunitz 
peptides for the first time from a lizard toxin-secreting gland, suggesting a potential 
ancestral role of this toxin in the Toxicofera clade. 
Toxins 
Venom proteins are likely the result of ‘toxin recruitment events’ (Fry, 2004), whereby 
genes encoding normal body proteins are duplicated and the new copy preferentially 
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expressed in the venom glands (Fry, 2005). Toxins are often exquisitely targeted and 
typically characterised by specific scaffold highly cross-linked with disulphide bonds that 
allow for greater proteolytic resistance than that of typical body proteins. 
The ancestral toxicoferan reptile is hypothesised to possess a core set of toxin genes, with 
additional genes added to the venom gland arsenal at different points in the evolutionary 
history of the clade (Fry et al., 2006, 2009, 2010a,b, 2013; Koludarov et al., 2012). Such 
toxins as AVIT, kallikreins, CRiSPs, NGF and hyaluronidase are present in different 
lineages of Toxicofera and their sequences have high similarity, with phylogenetic 
analyses recovering monophyletic origin of toxin forms (Fry et al., 2005 and 2010b; 
Koludarov et al., 2012). 
Additional toxins identified as present exclusively in lizard venoms are: helofensin (lethal 
toxin isoforms), exendin, B-type natriuretic peptides, and type III phospholipase A2 (Fry et 
al., 2006; 2009; 2010b). In addition, helokinestatin peptides are unique proline-rich de 
novo derivations within the precursor region of the natriuretic peptides. Post-translational 
cleavage liberates the helokinestatin peptides to act as independent toxins. Currently they 
are thought as unique to Heloderma and anguid lizards, for varanid natriuretic peptides 
studied to date lack these derivatives (Fry et al., 2010a,b; Koludarov et al., 2012). The full 
list of toxins currently known from anguimorph lizards is presented in Table 1. 
Table 1 Toxins found in anguimorph lizards oral secretion 
Protein type/toxin 
class 
Toxin action 
Exendin Induces hypotension via relaxation of cardiac smooth muscle. 
Kallikrein Increase of vascular permeability and production of hypotension in 
addition to stimulation of inflammation 
CRiSP (cysteine rich 
secretory protein) 
Paralysis of peripheral smooth muscle and induction of hypothermia 
through blockage of various channels including ryanodine and L-type 
calcium channels 
B-type Natriuretic 
peptide/helokinestatin 
Natriuretic peptides produce hypotension through the relaxation of 
aortic smooth muscle. The helokinestatin peptides are antagonists of 
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precursor bradykinin at the B2 bradykinin receptor. 
Phospholipase A2 
type III 
Block of platelet aggregation 
Nucleosides Potentially hypotension, paralysis, necrosis 
Vespryn Induces hypolocomotion and hyperalgesia. 
Hyaluronidase Enhancement of tissue permeability 
Kunitz peptide Protease inhibtion 
Goannatyrotoxin  Induces hypertension followed by hypotension 
Helofensin Lethal toxin which possesses an inhibitory effect on direct electrical 
stimulation of the isolated hemi-diaphragm. 
Celestoxin  Induces hypotension 
C-type lectin Platelet aggregation mediated by galactose binding. 
AVIT Toxic activity currently uncharacterised. 
Cholecystoxin  Toxic activity currently uncharacterised. 
Veficolin Toxic activity currently uncharacterised. 
NGF Toxic activity currently uncharacterised. 
VEGF Toxic activity currently uncharacterised. 
Hepatocyte growth 
factor 
Toxic activity currently uncharacterised. 
 
Traditionally, reptile venom research has been focused on clinically important species. As 
a result, our understanding of the evolution of venom systems in most toxicoferan reptiles 
is limited. Previous studies of venomous but harmless to human lizard species showed 
that a wide range of venom components were present in the venom-gland transcriptomes 
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of such lizards (Fry et al., 2006, 2010b; Koludarov et al., 2012). Consistent with use in prey 
capture, some components showed an evidence of rapid evolution. Helokinestatin 
peptides in particular accumulated residues that underwent episodic diversifying selection. 
In contrast, natriuretic peptides have evolved under evolutionary constraints despite being 
encoded in tandem with helokinestatins by the same gene precursor. 
Exendins 
Exendins are secretin hormone-like peptides that were isolated from the venom of 
helodermatid lizards. Exendins-1 and -2 are vasoactive intestinal peptide (VIP)-like, both in 
sequence and function, while exendins-3 and -4 are glucagon-like peptide-1 (GLP-1)-like 
(Irwin 2012). Previously names helospectin and helodermin were used for exendin-1 and 
exendin-2 respectively. 
Occurrence of different exendin forms seems to differ between Heloderma species: 
exendin-2 and exendin-4 is apparently restricted to H. suspectum venom (Vandermeers et 
al., 1987; Eng et al., 1990). There is also a concentration difference between the forms: in 
H. horridum venom exendin-3 is 5 times more abundant in molar concentration than 
exendin-1 (Eng et al., 1990). Helodermatid adenylate cyclase activating peptide (PACAP), 
VIP and GLP show high sequence similarity to exendin peptides (Vandermeers et al., 
1987). 
There is evidence that exendin-4 is present in Heloderma plasma and therefore has a 
potential role as a metabolic hormone. However, it has been shown that its levels increase 
only when the feeding strategy involves bitting (Christel and Denardo 2006). Though the 
exact role exendin plays in plasma is yet to be uncovered, it is highly plausible that its 
occurrence in the blood is a byproduct of its primary function in subjugation of a prey. 
Given that it is one of the dominant components of the venom, it is not unlikely that it 
enters the stomach along with the meal and then is filtered into the blood due to its 
relatively small size. Of course it cannot be ruled out that it has a metabolic function, given 
its known ability to increase the circulation of insulin. 
Apart from occurring in helodermatid lizards’ venom, exendin-like peptides (in particular 
similar to exendin-1) were identified in high concentration in the thyroid C cells and in the 
noradrenaline containing cells of the adrenal medulla in many mammals (Sundler et al., 
1988; Grunditz et al., 1989; Bjartell et al., 1989; Grundemar and Högestätt, 1990; Uddman 
et al. 1999). 
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Structure 
Exendin-1 occurs as two isoforms in the venom of Heloderma suspectum. One isoform 
(dubbed helospectin-I) is a 38-residue peptide and another (helospectin II) is a 37-residue 
peptide identical to first one except that it lacks serine in 38 position.  
Exendin-2 is a 35-residue peptide. Both forms of exendin-1 as well as exendin-2 have high 
similarity with VIP with 15 of the first 28 residues being identical (Hoshino et al., 1984; 
Parker et al., 1984; Grundemar and Högestätt, 1990) and significant similarity with human 
pituitary adenylate cyclase activating peptide (PACAP) with exendin-2 being 42% identical 
to it (Vandermeers et al., 1987). The precursor transcript of an exendin-2 isoform was 
shown to have high sequence similarity to the precursors of exendins-3 and -4.  The signal 
peptide differed only in 3 residues from that of exendin-3 (Fry et al., 2012)  
Exendin-3 is a 39-residue peptide with an amide at the C-end. It has greater similarity with 
glucagon and human glugaonlike peptide-1 (48% and 50% respectively) than with 
exendin-1 and -2 (32% and 26% respectively) (Eng et al., 1990). 
Exendin-4 is a 39-residue peptide. Its cDNA is similar to exendin-2 both in size and 
structural organisation (in particular, the respective positions of the peptide and N-terminal 
extension peptide), suggestive of their evolution from a common ancestral gene through 
gene duplication event  (Vandermeers et al., 1987; Eng et al., 1992). It was shown to have 
a high stability to degradation mediated by DPPIV and ectopeptidases (Montrose-
Rafizadeh et al., 1997). NMR-study revealed a well-converged helix over residues 18-27 in 
both GLP-1 and exendin-4 in the conditions mimicking that just prior to binding to the 
receptor. Exendin-4 was shown to display a greater intrinsic propensity toward the 
formation of a monomeric helix than GLP-1, which can be attributed to the absence in 
exendin-4 of the helix-interrupting glycine residue at position 16 of GLP-1 (Neidigh et al., 
2001). This allows for the helix to go much further toward the N-terminus in exendin-4 that, 
along with other structural differences between GLP-1 and exendin-4, may reduce the 
entropic cost of binding and be responsible for the higher potency of exendin-4 in some 
organisms. 
Function 
Crude venom of Heloderma suspectum was shown to be a potent pancreatic 
secretagogue (Eng et al., 1990). Exendin-1 and -2 were found to have immunological and 
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biological properties similar to mammalian VIP while exendins-3 and -4, in contrast, have 
biological functions most similar to mammalian GLP-1 (Irwin, 2012). 
Both exendin-1 and -2 mimic VIP action in reducing blood pressure in the rat, however 
exendin-2 was shown to be less effective than VIP in the low dose-range, as well as VIP 
having longer duration that either of the peptides. In accordance with the vasodepressor 
effect, both exendin-1 and -2 were shown to relax precontracted femoral arteries, with 
exendin-1 being less potent than VIP or exendin-2. The maximum relaxation induced by 
the either of the three was of similar magnitude and further addition of any of the other 
peptides did not produce a further relaxation (Grundemar and Högestätt, 1990). 
Exendin-2 is at least partially responsible for the tachycardia seen in human 
envenomations (Naruse et al., 1986; Konturek et al., 1989). 
Similar to VIP, intraarterial infusion of exendin-2 causes a dose dependent increase in 
femoral blood flow and intravenous injection produces systemic hypotension and 
tachycardia in the dog models, though exendin-2 produced more long-lasting increase in 
canine femoral blood flow than VIP (Naruse et al., 1986; Konturek et al., 1989). 
Exendin-4 inhibits glucagon secretion (Silvestre et al., 2003), stimulates insulin synthesis 
(Alarcon et al., 2006) and secretion (Silvestre et al., 2003; Parkes et al., 2001), protects 
against b-cell apoptosis (Kawasaki et al., 2010; Wang et al., 2010) and promotes b-cell 
proliferation (Kwon et al., 2009). On an organismal level it was shown to promote satiety, 
reduce food intake, fat deposition and body weight both in normal animals and 
experimental models (Scott and Moran, 2007; Williams et al., 2009; Primeaux et al., 2010; 
Washington et al., 2010). 
Exendin-4 was shown to stimulate secretion of insulin in the presence of elevated blood 
glucose concentrations, but not during hypoglycemic periods, which led to its 
pharmacological use in the treatment of type 2 diabetes (Neidigh et al., 2001). Treatment 
with exendin-4 increases cell proliferation and neuroblast differentiation in the dentate 
gyrus, potentially through promoting structural plasticity (Li et al., 2010). 
The very first studied effects of exendin-1 and -2 was their ability to activate adenylate 
cyclase in plasma membranes of the rat pancreas (Vandermeers et al., 1984), but it is only 
exendin-2 that also induces amylase secretion (Konturek et al., 1989). Exendin-3 was 
shown to be similar in action to exendin-2, inducing the increase of cellular adenylate 
cyclase and releasing amylase in guinea pig pancreatic acini (Vandermeers et al., 1987). 
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Though exendin-3 amylase releasing activity was less potent that that of exenind-1, 
exendin-2 or VIP (Raufman et al., 1991).  
On the guinea pig pancreatic acini models exenndin-3 was shown to interact with VIP 
receptors at high concentration and with specific exendin receptor in lower concentrations. 
The former action is responsible for its amylase releasing activity through increase of 
cellular cAMP, while the latter activity results only in increase of acinar cAMP without 
stimulating amylase release (Raufman et al., 1991; Uddman et al. 1999). 
Exendin-4 was likewise shown to stimulate adenylate cyclase production with a potency 
and efficacy equal to or greater than that of GLP-1 and binding with a similar (in humans) 
and higher (w7.5 fold in rats) affinity to the mammalian GLP-1 receptor (Eng et al., 1990; 
Edwards et al., 2001; Egan et al., 2002; Mann et al., 2010). 
The adenylate cyclase activating effect is attributed to N-terminal regions as was shown 
for exendins-3 and -4, while middle and C-terminal regions influence binding affinity to the 
receptor (Eng 1992). N-terminal regions of exendin-3 and -4 are different by two amino 
acids, which were shown to be responsible for the lack of exendin-4 ability to interact with 
VIP receptors. This might be the reason why exendin-3 causes the biphasic increase in 
adenylate cyclase, while exendin-4 action is monophasic (Eng et al., 1992). 
The function of the N-terminal region is more than that though as an exendin-4 version 
truncated beyond the second N-terminal amino acid acts as a potent antagonist, rather 
than agonist, of the GLP-1 receptor (Eng 1990; Montrose-Rafizadeh et al., 1997). 
C-terminal sequence of 9 amino acids in exendin-4, absent in GLP-1 structure, is 
responsible for its high affinity to GLP-1 receptor in rats, its removal was shown to reduce 
the potency of binding and addition of the sequence to GLP-1 resulted in increase of 
potency (Doyle et al., 2003). However this sequence does not contribute to the binding of 
exendin-4 to human GLP-1 receptor (Runge et al., 2007), which might explain the 
aforementioned differential affinity to the receptor between exendin-1 and GLP-1 in rat in 
human models.  
Evolution  
The existence of exendin-like peptides in mammals, especially in the adrenal medulla 
(Bjartell et al., 1989; Grundemar and Högestätt, 1990), suggests a potential plesiotypic 
role of exendins in cardiovascular regulation. 
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Despite the earlier speculation of exendin-2 and -4 being evolutionary precursors to the 
mammalian members of glucagon-like peptide family (PACAP, VIP and GLP-1) based on 
similarity in activity between those groups, it was revealed that they are not evolutionary 
closely related (Vandermeers et al., 1987; Pohl and Wank, 1998). The finding is also 
corroborated by the fact that exendins’ expression in Heloderma seems to be limited to 
venom glands only (Vandermeers et al., 1987). 
Differences in biological activity within exendins, in particular similarity between VIP and 
exendins-1 and -2 and between GLP-1 and exendins-3 and -4 led to uncertainty weather 
exendins are derived versions of VIP or GLP-1 or even a result of convergent evolution. 
Genetic studies ruled out the last possibility and showed that exendins are in fact closely 
related to each other and the signal and pro-peptide sequences have greater similarity 
between themselves then to the corresponding regions of any other secretin-like hormone 
precursor (Irwin, 2012). Since the glucagon and VIP genes are situated on different 
chromosomes in various vertebrates, it is very likely that the genomic separation between 
the two occurred in the early evolution of the common vertebrate ancestor and therefore 
the interchromosomal shuffling of exons was the unlikely reason for the differences 
between the exendins. 
Two most likely scenarios of exendins’ evolution were proposed with one involving 
duplication of a glucagon gene followed by an additional duplication event and convergent 
evolution of exendins-1 and -2 sequences to the VIP sequence, and another involving 
duplication of the VIP gene with a subsequent duplication event and convergence of the 
exendin-3 and -4 sequences with that of GLP-1.  
A glucagon-like gene identified in anole lizard suggested that a first scenario is more likely 
than the second. Not only the gene sequence was most similar to proglucadon-derived 
sequences of other vertebrates as well as exendin sequences from Heloderma, it also had 
intron that was homologous to those of the proglucagon and GLP genes. The altogether 
position of introns and exons, including flanking splice donor and acceptor sequences was 
found similar to that of other proglucagon genes (Irwin, 2012). 
Comparison of the exendin sequence of helodermatid lizard with that of anole lizard, zebra 
finch, turkey and Xenopus suggested that exendin genes exist in a conserved 
neighborhood, strongly indicating that they are orthologous. Phylogenetic trees built with 
just the exendin precursor sequences showed that there is an extremely long ancestral 
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lineage leading to the Heloderma exendins. Phylogenies generated with just the N-
terminal signal peptides produced identical topologies for all the different exendins used, 
however the length (amount of sequence change) leading to Heloderma was much 
shorter. Exendin sequences showed the length (amount of sequence change) of the 
ancestral lineage leading to Heloderma exendins becoming exaggerated, and disturbed 
the monophyletic groupping of reptilian and avian sequences. All of that indicated a more 
rapid evolution of exendin sequence in Heloderma lineage as compared to other 
vertebrate lineages. At the same time the rate of evolution of pro-peptide and signal-
peptide regions stayed the same across all studied lineages (Fry et al., 2012; Irwin, 2012). 
Reconstruction of the ancestral sequence of the Heloderma exendins further corroborated 
proglucagon-like origin scenario. When compared to the extant exendins, it was found to 
be most similar to GLP-like exendins-3 and -4 with 5 and 7 substitutions respectively, while 
showing 15 and 17 replacements with exendins-1 and -2 (Irwin, 2012). 
These findings suggest that Heloderma exendins diversified by gene duplication after 
Heloderma lineage diverged from other reptiles. As the peptides were adapting to a new 
role as toxins, their sequence rapidly evolved – a phenomenon well associated with the 
recruitment of body protein for the use as a toxin.  
It was shown that VIP hormones are more potent vasodilators than endogenous glucagon 
hormones (Ezawa et al. 2006) making it likely for the selection to favor the evolution of a 
toxin that mimics VIP action then for the VIP-like peptide to evolve into a less potent 
glucagon-like form. These suggests that while exendin-3 and -4 retained the ancestral 
structure of proglucagon-derived family, exendin-1 and -2 convergently evolved the 
structure similar to that of VIP, resulting in similar bioactive properties and a long-lasting 
confusion of their origin (Fry et al 2010b).  
Medicinal use of exendin-4 
The discovery of GLP-1 like action of exendin-4 rapidly led to numerous studies on its 
potential anti-diabetic effects. They show that continuous administration of exendin-4 in 
diabetic mice, diabetic and obese-diabetic rats, diabetic rhesus monkeys result in 
increases in concentration of circulating insulin accompanied by reductions in blood 
glucose and glycosylated haemoglobin (Greig et al., 1999; Young et al., 1999; Gedulin et 
al., 2005). Exendin-4 was shown to stimulate b-cell neogenesis in some type 2 diabetes 
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animal models, while stimulating the replication and differentiation of islet cells in others 
(Xu et al., 1999; Tourrel et al., 2002). 
In humans, exendin-4 reduced fasting and postprandial blood glucose in healthy 
volunteers and improved b-cell sensitivity to glucose and reduced blood glucose in type 2 
diabetes patients (Edwards et al., 2001; Egan et al., 2003; Kolterman et al., 2003; Buse et 
al., 2004, 2009; DeFronzo et al., 2005; Moretto et al., 2008; Preumont et al., 2010; Bunck 
et al., 2010). 
Despite its ability to cause antibody formation similar to any other subcutaneously injected 
peptide, no safety and efficacy concerns were shown in exendine-naive patients. Study on 
anti-exendine antibody formation and the incidence of immune-related and hypersensitivity 
reactions after exendine re-exposure found no increase in treatment-emergent adverse 
events (Faludi et al., 2009). 
Synthetic exendin-4 was released as a type 2 diabetes treatment under the market name 
“Byetta” (Furman, 2012). 
Kallikrein 
Kallikrein-scaffold forms of S1 peptidase family are broadly represented in reptile venoms 
with 250 toxin forms, a majority of which were recovered from viperid snakes. Toxicoferan 
venom kallikreins (TV-kallikreins) mostly affect blood pressure and coagulation through 
their proteolytic activity, most importantly liberating kinins from plasma kininogen or 
depleting plasma of fibrinogen by cleaving it to facilitate blood loss. Only half of toxicoferan 
venom kallikreins have been functionally characterized. A number of kallikreins were 
recovered from Anguimorpha lizards with two major examples being helodermatine and 
gilatoxin, both isolated from helodermatid lizards’ venom. TV-kallikreins have a potential 
for medicinal use due to their ability to alter hemostasis with one instance of snake 
kallikrein developed into an anticoagulant under the commercial name “Arvin” (Fry et al., 
2009a; Fry, 2015) 
Structure 
Toxicoferan venom kallikreins have evolved from glandular/tissue kallikreins and are 
similar to them in structure and most of their functions. They are single-chain proteins with 
a sequence length of usually about 230 amino acids, preceded by 6 residues of activation 
peptide and 18 residues of signal peptide. Proteolytic domain contains Ser/Gly189 or 
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Asp189 (α-chymotrypsin numbering) and is located between two antiparallel six-stranded 
β-barrels. All toxicoferan venom kallikreins have 5 or 6 cystines stabilizing their structure.  
Viperid and some elapid forms of toxin kallikreins possess C-terminal 7 amino acid 
extension with an additional cysteine residue, while anguimorph lizards’ kallikreins lack the 
extension and instead have a cysteine-carrying insertion of 6-9 amino acids in-between 
positions 93-95. Other structural variations occur mainly in surface loops. TV-kallikreins 
are usually heavily glycosylated and that can significantly increase their predicted Mw of 
26-28 kDa. The isoelectric point is usually between 5 and 7 or 8 and 9, but can be as low 
as 4 (Fry, 2015). 
Gilatoxin isolated from the venoms of Helodermatid lizards is a monomeric acidic kallikrein 
of Mw in the range of 30-37 kDa and an isoelectric point of 3.9-4.25 (Hendon and Tu 1981; 
Nikai et al., 1988). The complete sequence includes 246 residues. Gilatoxin is highly 
glycosylated, containing approximately 8 mole of monosaccharide per mole of toxin, but 
appears to lack O-glycosylation sites. Sequence alignments of gilatoxin with batroxobin, 
crotalase, thrombin and trypsin revealed its considerable similarity to those enzymes, 
particularly in the catalytic site. The highest sequence identity (40%) was with batroxobin 
(Utaisincharoen et al., 1993). 
Previously, gilatoxin was reported to have an additional 7 residues extension (including 
Asp-96, in the basic specificity pocket of thrombin), which was thought to contribute to the 
unusual substrate specificity of the toxin (Utaisincharoen et al., 1993). Recent studies 
demonstrated that sequence used in 1993 analysis is not authentic and all other gilatoxins 
lack this extension (Fry et al., 2010b). Gilatoxin from Heloderma horridum venom was 
shown to have Mw of 31 kDa and isloelectric point of 3.9. It was found to be similar to 
porcine pancreatic kallikrein with homologous sequences in N-termial region (Nikai et al., 
1988). 
Similar to other TV-kallikreins, varanid forms show a conservation of functional residues 
and cysteine spacing. However two forms from V. acanthurus and V. scalaris were shown 
to evolve new instance of cysteine absent in the ancestral condition. At the same time 
kallikrein toxins recovered from Celestus warreni and Gherronotus infernalis show not only 
a newly derived cysteine not present in other sequences but also the loss of the last 
ancestral cysteine (Fry et al., 2010b). 
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Function 
Toxicoferan venom kallikreins perform a range of functions in the bite and largely 
contribute to the profound, rapidly developing swelling characteristic of viperid snakes and 
anguimoprh lizards’ bites. Similar to tissue kallikreins they evolved from, TV-kallikreins’ 
main activity lies in processing of low-Mw kininogens into kallidin (Lys-bradykinin). This 
leads to inflammation, smooth muscle contraction, lowered blood pressure and increased 
vascular permeability. Other major activities of TV-kallikreins include angiotensinolytic 
activity, resulting in hypotension and fibrinolytic activity, resulting in unstable clots, 
depletion of fibrinogen and clotting inhibition (Fry et al., 2015). 
Kinin-generating activity of the Heloderma suspectum venom was discovered by Mebs 
(Mebs, 1969a) and was later attributed to helodermatine (Alagon et al., 1986). 
Helodermatine was shown to cleave synthetic peptide substrates with similar kinetics to 
serum kallikrein, realeasing 75% of the amount of kinin from human high-Mw-kininogens 
similar to human plasma kallikrein. This might be indicative of another function of 
helodermatine in venom, potentially converting toxins precursors into active forms (Alagon 
et al., 1986). Since several tissue kallikreins are known to process insulin and glucagon, it 
is not unlikely that helodermatine or gilatoxin play a role in processing of exendins in 
Heloderma venom. 
Helodermatine was found to produce hypotensive effect in rabbits and is responsible for 
hypefibrinolytic state at the site of the Heloderma bite (Alagon et al., 1986). Similarly, 
gilatoxin lowered blood pressure in rats and induced contraction of isolated rat uterus 
smooth muscle. 
In accordance with plesiotypic functions for TV-kallikreins, gilatoxin was shown to release 
bradykinin from kininogen. It catalyzed the hydrolysis of various substrates for trypsin and 
thrombin and degraded both angiotensin I and II by cleaving the dipeptide Asp-Arg from 
the N-terminus. It was shown to have higher substrate specificity than trypsin and being 
very similar to plasma kallikrein. Gilatoxin degrades fibrinogen without clot formation 
(Utaisincharoen et al., 1993), which should lead to further clotting inhibition. 
Toxicity of anguimorph kallikreins is thought to be moderate. For instance, gilatoxin’s 
toxicity toward Swiss-Webster mice is 2.5 pg/g body weight (IV LD50) (Utaisincharoen et 
al., 1993). 
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Structure-function mechanics of TV-kallikreins are poorly understood. However the 
variation between Gly/Ser189 and Asp189 in catalytic site is thought to correspond to 
difference in substrate specificity (Fry et al., 2015). 
CRiSP 
Cysteine rich secretory proteins (CRiSPs) are part of CAP (cysteine-rich secretory 
proteins, antigen 5, and pathogenesis-related 1 proteins) superfamily and act as inhibitors 
of a number of ion channels. Reptilian venoms are rich in CRiSPs, in particular venoms of 
non-front-fanged snakes and anguimorph lizards, but the toxic role of these proteins 
remains enigmatic. It is most likely that they disrupt homeostasis through the blockage of 
cyclic nucleotide-gated and voltage-gated ion channels, as well as inhibition of smooth-
muscle contraction. A number of CRiSPs were recovered from Anguimorpha and Iguania 
lizards’ oral secretion (Fry et al., 2009a; Fry, 2015). 
Structure 
CRiSPs are single chain proteins with a sequence of approximately 230 amino acid 
residues and Mw of 20-30 kDa. All CRiSPs have universally conserved 16 cysteine 
residues that form 8 cystines responsible for the great stability of the structure (Lyns, 
2007). CRiSP molecule has two distinct domains separated by a hinge region: 21 kDa 
structurally conservative CAP (PK-1) at the N-terminus and 6 kDa CRD (cysteine rich 
domain) at the C-terminus, with the latter containing 10 out of 16 cysteine residues. Even 
though CRiSPs lack transmembrane domain, they can associate with membrane 
components through interactions with membrane proteins (Fry et al., 2015) 
Helothermine, isolated from Heloderma horridum (Mochca-Morales, Martin and Possani, 
1990), has a Mw of 25 kDa and consists of 223 amino acids, its structure stabilized by 
eight disulfide bridges. It has significant similarity with CRiSPs from human (49,6%) and 
mouse (46.7%) testes, as well as CRiSPs found in mouse salivary glands and mouse and 
rat epididymis (Morrissette et al., 1995). 
While most details of CRiSPs’ function remain to be elucidated, it is hypothesized that their 
distinct two-domain structure allow for the dual function, with CRD being responsible for 
the ion-channel binding activity. 
Varanid CRiSPs were shown to have the loop I doublet (KR) that is thought to be an 
essential part of the blockage of cyclic-nucleotide-gated calcium channels. Helothermine 
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as well as most varanid CRiSPs also have the loop I motif (EXXF) that is thought to 
facilitate blockage of the L-type Ca channels and contribute to the inhibition of smooth 
muscle contraction (Fry et al., 2006). 
Anguimorph CRiSPs were shown to have variation in structural and functional domains, 
including in the ion channel-binding region (CRD). Similar to kallikreins, their cysteine 
pattern remains highly conserved, with only Celestus warreni and Varanus indicus so far 
revealed to possess newly evolved cysteines (Fry et al., 2006).  
Function 
Organismal effects of CRiSP toxins are diverse. Injections of the purified helothermine 
produced lethargy, rear limb paralysis, hypothermia, and death in rodents (Mochca-
Morales et al., 1990). 
Helothermine was found to produce a strong and constant inhibition of ryanodine binding 
to cardiac and skeletal sarcoplasmic reticulum with a more pronounced effect on skeletal 
receptor. It was shown that helothermine interacts with ryanodine receptors in a very 
selective manner, most likely lowering the Ca sensitivity of the channel through selectively 
decreasing the number of release sites (Morrissette et al., 1995). Helothermine was also 
shown to block K+ and Ca2+ currents in rat cerebellar cells (Nobile et al., 1994, 1996). 
While the physiological targets of helothermine are unknown, its toxic action in rodents 
likely includes either assistance by other venom components (such as PLA2) or cleavage 
of the whole protein into a smaller fragment in order to facilitate penetration of the muscle 
cells to produce a direct block of ryanodine receptor (Morrissette et al., 1995).  
Evolution 
Toxicoferan venom CRiSPs form two distinct lineages with a high likelihood of separate 
events leading to their recruitment. Snakes’ CRiSPs are more diverse and have more sites 
under the influence of positive selection than their lizards’ counterparts (Sunagar et al., 
2012). 
Natriuretic/helokinestatin peptides 
Natriuretic peptides are a vast group of molecules performing diverse physiological roles. 
They have been independently recruited as toxins in mammalian (platypus) and reptilian 
venoms. Anguimorpha lizards’ venom natriuretic peptides belong to a group B of 
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natriuretic peptides and are thus called LV-BNP. There are three target guanylyl cyclase 
receptors associated with the activity of natriuretic peptides. GC-A and GC-B are the 
primary targets of LV-BNPs, they trigger secondary pathways of intracellular guanylyl 
cyclase. GC-C is a secondary target mediating the activity through G-protein dependent 
pathways (Fry et al., 2009a; Fry, 2015).  
Helokinestatins are a family of proline-rich peptides originally isolated from H. suspectum, 
they were later found to be present in venoms of other members of Anguimorpha family – 
Gherronotus infernalis and Celestus warreni (Fry et al., 2010b). Helokinestatins act as 
inhibitors of bradykinin action on smooth muscle (Kwok et al., 2008) and represent one of 
the apotypic lineages of evolution of toxic natriuretic peptides in reptiles, another being 
snake venom BPPs (Ma et al., 2011).  
Structure 
All natriuretic peptides are expressed as a long precursor containing signal peptide, 
propeptide and natriuretic peptide domain that is post-translationally cleaved to liberate 
individual NP. All natriuretic peptides have 17-amino-acid disulfide loop, all lizard 
natriuretic peptides have a C-terminal tail, that sets them apart from snake NP (Fry, 2015). 
Helokinestatins are usually small peptides with Mw of 1 to 1.5 kDa. To date seven 
isoforms have been identified in the Heloderma venoms with their nomenclature reflecting 
their position on the precursor. All helokinestatins are rich in prolyl residues, which impose 
certain rigidity and spatial order on their structure and makes them resistant to non-specific 
proteolysis (Fry et al., 2010a; Zhang et al., 2010; Ma et al 2011). All helokinestatins 
possess a Pro-Arg motif at C-terminus as opposed to Ile/Val-Pro-Pro motif of snake venom 
BPPs. All helokinestatins are encoded as tandem repeats within the natriuretic peptide 
precursor (Fry et al., 2010a,b, 2012; Zhang et al., 2010). 
Helokinestatins have a highly conserved structure among anguimorph lizards, which is 
suggestive of their fundamental function in the venoms of this clade (Ma et al., 2011). 
Between the species of Heloderma several helokinestatins are fully-conserved in primary 
structure while others are different. 
Differences between the species occur also in the length of the precursor. One precursor 
sequence was identified to have an open-reading frame of 196 amino acids in H. horridum 
and 178 residues in H. suspectum. The difference is due to the insertion of an additional 
domain of 18 residues coding helokinestatin-3 molecule. In H. horridum precursor 
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sequence encodes one copy of helokinestatin-1, one copy of helokinestatin-2, two tandem 
copies of helokinestatin-3 (that set it apart from H. suspectum version), a single copy of 
helokinestatin-6 and a single copy of C-type natriuretic peptide (Ma et al., 2011).  
Function 
Helokinestatins antagonize the actions of bradykinin on mammalian smooth muscle (Kwok 
et al., 2008) unlike the bradykinin-potentiating peptides (BBPs) isolated from venoms of 
certain snakes.  
Synthetic replicates of helokinestatins 1–3 and 5 were all found to antagonize the 
relaxation effect observed following bradykinin application to a rat arterial smooth muscle 
preparation in a manner that suggested a non-competitive mode of action. This effect was 
also more pronounced than that recorded for guinea pig ileum smooth muscle (Zhang et 
al., 2010). However, unlike all other members of the family, Helokinestatin-7H induces a 
dose-dependent contraction of rat arterial smooth muscle (Ma et al., 2012). 
Due to the tandem-repeat nature of the evolution of this peptide family, most forms are just 
structurally slightly different versions of each other. At the same time, even single 
substitution can have a dramatic effect on the peptide’s bioactivity. A helokinestatin-2 
isoform from H. horridum has a single phenylalanine substitution which can be attributed to 
the differential potency of both forms (with and without substitution) in attenuating 
bradykinin responses on arterial smooth muscle, with the substitution causing an almost 
50% reduction in activity. Another example is helokinestatin-6 that has an unusual C-
terminal sequence of EPR that results in it being the least potent of helokinetsatins in 
bradykinin inhibition (Ma et al., 2011). 
This feature is further elucidated by helokinestatin-7 forms that differ in having Arg/Thr at 
position 6 and Lys/Glu at position 7. These changes increase the net negative charge of 
the molecule with helokinestatin-7H having -1 and helokinestatin-7S having -4, at the 
same time most other helokinestatins exhibit a net positive charge of +2 which, along with 
the higher presence of prolyl residues, might explain the lower potency of helokinestatin-7 
forms as bradykinin antagonists since their physiochemical properties are closer to that of 
the appropriate ligand (Ma et al., 2012). 
To date no varanid helokinestatin forms were recovered, and varanid natriuretic peptides 
were shown to have retention of the residues necessary for natriuretic activity (Fry et al., 
2006), which might be indicative of low importance of this toxins in varanid lizards’ venom. 
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Natriuretic peptide from G. infernalis was shown to have hypotensive effect, with aspartate 
at ring-position 7 and isoleucine at ring-position 9 being important for this activity. While 
aspartate 7 replacement was affecting it more than isoleucine 9, both were shown to be 
important for full activity (Fry et al., 2010b).  
Evolution 
Snake venom BPPs were shown to encode a single copy of a peptide exhibiting a closer 
structural similarity with helokinestatins, in addition having similar propeptide convertase 
site cleavage specificity – properties otherwise outlining the differences between 
helokinestatins and BPPs (Zhang et al., 2010). However, phylogenetic studies show that 
lizard venom natriuretic peptides are the result of a recruitment event independent to that 
of the snake venom natriuretic peptides. In phylogenetic studies, lizard venom natriuretic 
peptides are nested within the BNP clade, while snake forms are nested within the CNP 
clade – two different types of natriuretic body peptides (Fry et al., 2010b). 
In this line of evidence helokinestatins are likely to occur early in the Neoanguimorpha 
clade, given their wide present in the oral secretion of relatively-distantly related 
neoaguimorph lizard lineages. This is further corroborated by the absence of novel 
helokinestatin domains within the natriuretic precursor gene of varanid lizards (Fry et al. 
2006, 2009b) and the differential rate of evolution between the scaffold of natriuretic 
peptides and helokinestatins in Abronia graminea (Koludarov et al., 2012). 
Medicinal potential of helokinestatins 
Helokinestatins were found to act synergistically with some anticancer drugs and evoke 
prostaglandin production (Kwok et al., 2008), which might lead to the development of a 
medicinal drug based on helokinestatin. 
Phospholipase A2 type III 
Phospholipases A2 are low-molecular weight enzymes that catalyze the hydrolysis of ester 
bond in glycerophospholipids. Being one of the largest groups of lipid-hydrolyzing 
enzymes, phospholipases have been convergently recruited into toxin arsenals of 
cephalopods, cnidarians, insects, arachnids, reptiles and other lineages. There are three 
classes of PLA2s, with groups I and II finding their way into snakes’ venom and group III 
present in the venom of anguimorphs (Fry et al., 2009a; Fry, 2015). 
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Initially phospholipases A2 type III were thought to be present only in the venom of 
helodermatid lizards (Dehaye et al., 1984; Sosa et al., 1986), however subsequent studies 
revealed their presence in a broader spectrum of anguimorph lizards’ oral secretion (Fry et 
al., 2006; Fry et al., 2009b; Fry et al., 2010b; Koludarov et al., 2012), thus suggesting its 
plesiotypic role in Anguimorpha clade. 
Structure 
Anguimorph lizards’ secretory anionic phospholipases A2 belong to unique class III of this 
protein family, with the snake phosopholipases compromising class I and mammalian 
pancreatic ones as well as some snakes’ belonging to class II. They usually have a 
sequence of around 140-160 amino acids with Mw around 16-19 kDa. Their cysteine 
pattern (usually 10 half-cystine residues), short hydrophopic N-terminus and C-terminal 
region sequence making them closely related to bee venom phospholipase A2 than to any 
other (Gomez et al., 1989; Vandermeers et al., 1991; Huang and Chiang, 1994). 
Within Heloderma alone several forms of PLA2s were identified with up to 15% difference 
in sequence that results in differential bioactivity. The N-terminal part, including the lipid-
binding area remains invariant. Active site and C-terminus also remain quite conserved 
with differences between the forms mostly occurring in the region separating the two 
(Vandermeers et al., 1991). 
Function 
PLA2s from H. horridum were shown to exclusively inhibit thromboxane-induced platelet 
aggregation of human platelet-rich plasma probably by virtue of their phospholipase 
activity on plasma phospholipids, converting them into lysophospholipids, which then 
interfere with the coupling of TXA, receptor and its signalling transduction system. 
However they had little effect on collagen- and ADP-induced platelet aggregation (Huang 
and Chiang, 1994).E 
Evolution 
Similarities between honeybee PLA2s and that of Heloderma lizards and the differences in 
PLA2 structure between anguimorph lizards and other toxicoferans hint at the possibility of 
ancient gene duplication event occurring in a provertebrate ancestor. One branch then 
putatively led to bee and lizard forms with 4 and 5 disulfide bonds and another after 
experiencing additional duplication event within the reptiles led to type I and II PLA2s with 
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7 and 6 disulfide bonds respectively (Gomez et al., 1989). Though it might be that 
Heloderma PLA2 type III evolved from ancestral reptilian PLA2 of uncertain type, the 
striking similarity between PLA2 from Heloderma venom and arthropodian venom type III 
PLA2s all of which form monophyletic clade (Ghomashchi et al., 1998; Hariprasad et al., 
2009) and the wide-range study showing that at least two PLA2 genes existed in the 
vertebrate line before divergence of reptiles and mammals (Davidson and Dennis, 1990) 
point towards the model of PLA2 type III evolution proposed by Gomez. 
Nucleosides and nucleoside-releasing enzymes 
Nucleosides are a known component of toxicoferan venoms, corresponding to as much as 
8.7% of the dry weight in some cases (Aird, 2005). Nucleosides were found to be present 
in venoms of Heloderma horridum and Heloderma suspectum though in smaller amounts 
than in many elapid or viperid venoms (Aird, 2008). Both exogenous venom nucleosides 
and endogenous nucleosides released from prey tissue have a complex function in 
reptilian venom, simultaneously immobilizing the prey via both hypotension and paralysis, 
and contributing to prey digestion via apoptosis and fast necrotic cell death (Aird, 2002). 
Since they have similar pharmacological roles in all vertebrates they are useful against all 
types of vertebrate prey. Many non-toxic venom components may exert a toxic role via 
meditating release of endogeneous nucleosides in the prey. 
Structure 
Aird (2008) reported presence of adenosine, cytidine, guanosine, hypoxanthine, inosine, 
and uridine in venoms of both Heloderma horridum and Heloderma suspectum. 
Fry et al. (2010b) reported ribonuclease sequences from G. infernalis that lack two 
ancestral cysteines as opposed to body form. Two of those isoforms had a frameshift 
mutation in the C-terminal region, which resulted in aformention lack of ancestral cysteines 
and presence of two new ones. 
Function 
Helodermatid nucleosides are likely to act in concert with kallikreins, exendins and 
helothermine in inducing hypotension in prey. At the same time no significant nucleoside-
releasing activity was found in Heloderma venoms (Aird 2008). 
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Other toxins 
A number of other toxins and potentially toxic enzymes were identified in anguimorph 
lizards’ venom glands or oral secretion. 
Serotonin was reported as a minor component in Heloderma venoms, but its toxic role 
remains unclear (Strimple et al., 1997). Likewise the functions of vespryn (Fry et al., 
2010a), NGF, VEGF, hepatocyte growth factor, peroxiredoxin, semaphoring 3E and other 
minor components discovered recently in Anguimorph venom (Sanggaard et al., 2015) 
remain to be elucidated. Since most of those proteins were recovered indirectly, they are 
yet to be properly charachterised. 
A lethal toxin-1, a protein of 28 kDa was shown to have inhibitory effect on direct electrical 
stimulation of the isolated mouse hemidiaphragm (Komori et al., 1988). Later study 
recovered the entire precursor gene of lethal toxin-1 orthologs, showing it to be 
constructed of beta-defensin domain repeats, therefore naming the toxin group 
“helofensins” (Fry et al., 2012). Helofensins evolved from an ancestral beta-defensin 
precursor through three domain duplication events, making it a third known independent 
recruitment of beta-defensin as a toxin with the other two being crotamine and platypus 
toxin. 
AVIT peptides are a plesiotypic group of toxicoferan toxins with a significant similarity with 
bioactive components from firebellied toads’ (genus Bombina) defensive skin secretions. 
They are potent agonists of mammalian prokineticin receptors and their effect mimics that 
of an endogenous prokineticin overdose leading to a rapid constriction of intestinal smooth 
muscles. AVIT have been isolated from snakes’ venom and several members of Varanus 
genus (Fry et al., 2010b). 
Fry et al. (2010b) report three new peptides with their toxin function inferred from their 
structure and location: cholecystoxin from V. varius, celestoxin from C. warreni, and 
goannatyrotoxin from V. glauerti. Cholecystoxin was found to be homologous to normal 
body cholecystokinin, while goannotyrotoxin homologous to YY peptides. Goannotyrotoxin 
had a potent hypertension activity followed by a prolonged hypotension. Celestoxin was 
found to be hypotensive and did not show any similarity with any known protein type. The 
same study recovered lectin from Psedopus apodus and lizard veficolin whose sequences 
formed a monophyletic group with snake forms, thus suggesting its plesiotypic toxicoferan 
role (Fry et al., 2010b). 
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Recent studies revealed presence of kunitz peptides in oral secretion of Anguimorpha 
venom (Koludarov et al., 2012; Fry et al., 2013). Kunitz peptides are present in a variety of 
snake venoms and are known to function as protease inhibitors and channel-blocking 
neurotoxins. Most reptilian venom kunitz peptides only known only through their primary 
sequence, with groups like textilins from Pseudonaja textilis being a stark exception (Fry, 
2015). Their role in Anguimorpha oral secretion as well as their evolutionary history within 
the Toxicofera remains to be elucidated. 
A presence of another core toxicoferan toxin – hyaluronidase was first inferred from the 
bioactivity of Heloderma venom (Tu and Hendon, 1983), with further study recovering 
hyaluronidase sequences from both H. suspectum and G. infernalis and showing their 
homology with snake venom hyaluronidases (Fry et al., 2010b). As can be inferred from 
their name, hyaluronidases catalyze hydrolysis of hyaluronic acid, a major component of 
interstitial barriers, thus increasing tissue permeability to allow for a more efficient 
spreading of other toxins. These enzymes are widely present in animal venoms with little 
sequence diversity across the taxa (Fry et al., 2009a; Fry, 2015) 
Concluding remarks 
For a long time venom research has had its focus fixed upon medically important species, 
resulting in a subtle anthropocentric bias in purely biological endeavours such as the 
application of the function concept and the study of evolutionary trends. The tides are 
changing now, with an ever-increasing amount of evidence outlining the role venom 
systems have played in the diversification of some reptilian lineages. 
If we put lizard venom research in perspective and take into consideration the fact that it is 
only four or five decades old, then we should view any criticism based on scarce evidence 
of functional role as a criticism of the insufficient number of studies. The aim of this review 
was partially to facilitate the emergence of new studies in the area of functional 
characterization of lizard venoms by supplying an outline of the current knowledge on the 
topic. 
It has to be noted that the role venom plays in the evolutionary and life history of 
anguimorph lizards is likely drastically different to that which it plays in front-fanged or 
even non-front-fanged snakes. In many venomous serpents venom is the only way to 
subdue a prey, while lizards usually have other ways of securing a meal, whether through 
the large blade-like teeth of varanid lizards or the powerful jaws of gila monsters. 
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Nevertheless, the reality of the presence of myriad toxins in the oral secretions of the 
Anguimorpha is inescapable, as is the homology of those molecules to their snake 
counterparts and their toxic activities – for those few that have been tested. It might be that 
venom plays largely a defensive role in the ecological realities of anguimorph lizards, it 
might be that it gives them a slight edge, marginally increasing their predatory success 
rates – in nature a slight effect may be enough to favour the selection of a functional trait. 
It is also likely that not all proteins secreted by venom glands have toxic role, perhaps 
acting as antimicrobial agents or digestive enzymes. However, a surplus of evidence is 
telling us that anguimorph lizards possess a unique and complicated oral secretory 
apparatus that produces myriad molecules with diverse exogenous effects. Such an array 
requires resources for its production, suggesting these molecules have been playing and 
continue to play an important role in the evolutionary reality of anguimorph lizards. 
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Fossilized venom: the unusually conserved venom profiles of 
Heloderma species (beaded lizards and gila monsters) 
Abstract  
Research into snake venoms has revealed extensive variation at all taxonomic levels. 
Lizard venoms, however, have received scant research attention in general, and no 
studies of intraclade variation in lizard venom composition have been attempted to date. 
Despite their iconic status and proven usefulness in drug design and discovery, highly 
venomous helodermatid lizards (gila monsters and beaded lizards) have remained 
neglected by toxinological research. Proteomic comparisons of venoms of three 
helodermatid lizards in this study has unravelled an unusual similarity in venom-
composition, despite the long evolutionary time (~30 million years) separating H. 
suspectum from the other 2 species included in this study (H. exasperatum and H. 
horridum). Moreover, several genes encoding the major helodermatid toxins appeared to 
be extremely well-conserved under the influence of negative selection (but with these 
results regarded as preliminary due to the scarcity of available sequences). While the 
feeding ecologies of all species of helodermatid lizard are broadly similar, there are 
significant morphological differences between species, which impact upon relative niche 
occupation. 
Introduction 
There are five extant species of helodermatid lizards: Heloderma alvarezi, H. 
charlesbogerti, H. exasperatum, H. horridum and H. suspectum (Douglas et al., 2010; 
Reiserer et al., 2013). H. suspectum last shared a common ancestor with the other extant 
species approximately 30 million years ago. H. exasperatum and H. horridum, the other 
two species included in this study, last shared a common ancestor approximately 4 million 
years ago. All are native to the south-western part of the North American continent and 
inhabit rocky, semiarid and scrubland habitats. Such an absence of appreciable intraclade 
diversity in the ecology is reflected in the extremely overall morphological similarity of the 
species. These lizards are also characterised by having a very low metabolic rate and are 
known to exhibit a preference for low-body temperatures, spending most of the year at 
temperatures lower than 25 °C (Pianka and King, 2004). Helodermatid lizards raid the 
nests of birds and rodents but may also predate upon adult rodents (Beck, 2005; Fry 
personal observations). 
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The genus Heloderma has been recognised as venomous for more than a century. The 
teeth are deeply grooved and the glands are very large. Most cases of human 
envenomation involve lizards biting and holding with their strong jaws, sometimes for 
hours. Envenomations by helodermatid lizards may be clinically complex, with symptoms 
including extreme pain, acute local swelling, nausea, fever, faintness, myocardial 
infarction, tachycardia, hypotension, and inhibition of blood coagulation (Bogert and del 
Campo, 1956; Bouabboud and Kardassakis, 1988; Cantrell, 2003; Hooker and Caravati, 
1994; Miller, 1995; Strimple et al., 1997). Studies of helodermatid lizard venom have 
identified several components (Table 1). Of these, exendin-4, isolated from Heloderma 
suspectum venom, is a peptide agonist of the glucagon-like peptide (GLP) receptor that 
promotes insulin secretion. It has been clinically used to treat type 2 diabetes and to 
enhance plasma insulin secretion (Drucker and Nauck, 2006). 
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Table 1 Heloderma venom peptides/proteins which have been proteomically characterised (based on 
previous studies) 
Protein type/toxin 
class 
Toxic action  Uniprot accession #(s) 
14-3-3 Possible disruption of signal 
transduction, possible disruption 
of neuronal cells homeostasis 
by similarity 
CRiSP (cysteine rich 
secretory protein) 
 
Paralysis of peripheral 
smooth muscle and induction of 
hypothermia through blockage of 
various channels including 
ryanodine and L-type calcium 
channels. 
Q91055 
Exendin Induces hypotension via 
relaxation of cardiac smooth 
muscle. 
C6EVG1, C6EVG2, 
P04203, P04204, P20394, 
P26349 
Helofensin Lethal toxin that inhibits 
direct electrical stimulation of the 
isolated hemi-diaphragm. 
C6EVG6, D2X5W3, 
D2X5W4, Q7LZ31 
Hepatocyte growth 
factor-like protein 
Toxin action unknown predicted 
Hyaluronidase Increase of membrane 
permeability 
gi|190700985 
Kallikrein Increase of vascular 
permeability, production of 
hypotension, stimulation of 
inflammation in addition to 
cleavage of fibrinogen. 
P43685, C6EVG4, 
C6EVG5 
B-type Natriuretic 
peptide/helokinestatin 
precursor 
Natriuretic peptides 
produce hypotension through the 
relaxation of aortic smooth 
muscle. The helokinestatin 
peptides are antagonists of 
bradykinin at the B2 bradykinin 
receptor. 
C6EVG7, D7FB56, 
D7FB57, E8ZCG5 
Neuroendocrine 
convertase 1 
Potentially involved in 
activation of exendins 
predicted 
Peroxiredoxin-4 Toxin action unknown predicted 
Phospholipase A2 
(Type III) 
Inhibition of platelet 
aggregation via the epinephrine-
C6EVG9, C6EVH0 
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induced pathway 
Semaphorin-3E Toxin action unknown predicted 
Vascular 
Endothelium Growth 
Factor 
Potentially increases 
vascular permeability 
based on similarity 
Venom Nerve Growth 
Factor 
Toxin action unknown based on similarity 
 
Variation in venom profiles has been extensively documented between snake species of 
the same genus (Angulo et al., 2008; Calvete et al., 2007; Fry et al., 2005, 2002, 2003; 
Gutierrez et al., 2008; Lomonte et al., 2008; Mackessy, 2010; Salazar et al., 2009; Sanz et 
al., 2008, 2006; Tashima et al., 2008; Wagstaff et al., 2009) and between individuals of the 
same species, with intraspecific differences found among different geographic localities (Fr 
et al., 2002; Boldrini-Franca et al., 2010; Castro et al., 2013; Daltry et al., 1996; Forstner et 
al., 1997; French et al., 2004; Sunagar et al., 2014), and between juveniles and adults 
(Daltry et al., 1996; Calvete et al., 2009; Lopez-Lozano et al., 2002; Mackessy, 1988). 
Such taxonomic, geographic and ontogenetic variation has been linked to strong natural 
selection in response to differing prey species (Fry et al., 2003a,b,c, 2008; Daltry et al., 
1996; Sunagar et al., 2012, 2014; Brust et al., 2013; Casewell et al., 2013; Gibbs and 
Mackessy, 2009; Pawlak et al., 2009). 
Traditionally, reptile venom research has focused mostly on clinically important snake 
species. As a result, our understanding of the evolution of helodermatid lizard venom is 
limited. In this study, we compare the venom proteomes of H. exasperatum, H. horridum 
and H. suspectum in order to gauge the extent of the diversification in venom composition 
that has occurred over 30 million years since these species last shared a common 
ancestor (Douglas et al., 2010). 
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Results and Discussion 
 
Figure 1: Reduced and non-reduced tris-tricine 1D-gel comparison of H. exasperatum, H. horridum and H. 
suspectum. 
 
Shotgun sequencing recovered toxin types previously known from the Heloderma venom 
proteome: CRiSP, exendin, kallikrein, helokinestatin and Type III phospholipase A2. In 
addition, this analytical technique recovered types previously known only from 
transcriptome studies: hyaluronidase, natriuretic peptide and nerve growth factor.  
One-dimensional gel electrophoresis (1D-GE) utilizing the tris-tricine method indicated a 
gross overall similarity between the three venoms (Figure 1). For each species there was a 
notable difference between non-reduced (NR) and reduced (R) samples. Most notably, a 
100 kDa band was present in the non-reduced lanes but absent from the reduced lanes. 
Conversely, the reduced lanes exhibited a dark band at 50 kDa not present in the non-
reduced, indicating that the 100 kDa band was a disulfide-linked dimer.  
 66 
 
Figure 2: 2D-gel examination of H. exasperatum venom. 
 
2D gels (2D-GE) confirmed the striking similarity of the three venoms (Figures 2-4). While 
the venoms are broadly similar in overall protein composition, it is clear that there are 
significant differences in relative expression levels. This was most apparent in the PLA2 
region. While these variations may point towards differential evolution, they may be also 
the result of intergel variation or simply arbitrary variation in venom gland content between 
individuals at the time of milking. More extensive comparative sampling is required to 
elucidate individual variation versus species level variations. Regardless, the overall 
protein composition was vastly more conserved than has been noted even for closely 
related species of snake (c.f. Ali et al., 2014).  
2D-GE revealed in all venoms previously unknown venom components which were 
identified as bactericidal/permeability-increasing (BPI)-fold (all species) and semaphorin 
proteins by searching the LC-MS/MS results against our previously constructed H. 
suspectum venom gland cDNA library (Fry et al., 2010a,b). While semaphorin was 
identified in H. suspectum only, it must be noted that light spots located in similar regions 
of the H. exasperatum and H. horridum gels, for which mass spectrometry analysis was 
unable to provide an identity, suggest that this component is likely present in the other 
Heloderma venoms. mRNA sequences are given in supplemental file 1 and genbank 
accession numbers are KP224275 (BPI-fold) and KP224276 (semaphorin). Phylogenetic 
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analysis for both protein types identified Anolis genome sequences as the nearest known 
relative (Figures 5 and 6). The fact that both of these were identified as being transcribed 
by the venom gland indicates that they are indeed secreted by this gland and are not 
mucus contaminants. Therefore, they may play an as yet unidentified role in 
envenomation. 
 
Figure 3: 2D-gel examination of H. horridum venom. 
 
The precise role of venom in the ecology of helodermatid lizards remains unknown. Beck 
(Beck, 1990) considered it a “paradox” that helodermatid lizards hold on “with bulldog 
tenacity” when biting in apparent defence, thus increasing the lizard’s chance of injury or 
death. But this assertion merely reflects a common fallacy of evolutionary thinking – that 
the individual lizard is the “unit of selection”. As selection takes place at the level of the 
gene, the death of the individual lizard does not preclude strong selection for “bulldog 
tenacity” in defensive bites, as presumably this tactic maximises the unpleasantness of the 
encounter for the aggressor, thus ensuring it avoids such encounters in future. However 
the overall pharmacological profile of the venom includes components with lethal 
neurological effects or other severe physiological targeting, actions not consistent with a 
purely defensive role for the venom as defensive toxins are typically pain inducing 
(Casewell et al., 2013). Rather such lethal effects point towards the venoms having at 
least some role in predation. 
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Figure 4: 2D-gel examination of H. suspectum venom. 
 
Very few sequences are available and most are from H. suspectum and thus selection 
analyses must therefore be regarded as extremely preliminary. Regardless, pairwise-
estimation of omega [non-synonymous (dN) to synonymous (dS) ratio] in this study 
revealed a greater influence of negative selection on the major toxin-encoding genes of 
Heloderma lineage, even for comparisons between H. horridum and H. suspectum 
sequences. Although for the in of intraspecific comparisons, dn/ds values lower than 1 can 
mean both weak negative selection or very strong positive selection, we chose to interpret 
these results as a sign of negative selection, since it is consistent with the proteomic data. 
However we acknowledge the possibility that future studies with larger sampling size might 
prove our decision wrong. The absence of diversity in venom-composition and toxin-
encoding genes within the sister Heloderma lineages suggest that the venoms are not 
evolving under the diversifying selection pressure characteristic of the predator-prey 
“chemical arms races” in which venomous organisms utilising their venom for prey 
subjugation find themselves (Sunagar et al., 2014; Brust et al., 2013; Casewell et al., 
2013; Sunagar et al., 2012). However, as noted above, there are obvious variations in 
relative expression levels within toxin classes and thus these relative expression levels 
may be a novel form of diversification. 
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While the venom has actions consistent with predatory use, a defensive venom role is also 
supported by the aposematic colouration of helodermatid lizards, the fact that these lizards 
are slow moving and vulnerable above ground (the osteoderms in their skin are another 
line of defence against would-be predators), and the fact that the lizards often feed on 
“defenceless” prey such as eggs and nestlings (Pianka and King, 2004). That being said, 
the results of the present study do not refute the hypothesis that helodermatid lizard 
venom may be used (at least partially) for predation, as all species occupy similar 
ecological niches and therefore feed on similar prey items. It must be emphasised that 
some toxins have actions consistent with predatory effects including lethal effects upon 
blood pressure, coagulation and neurological function. More in-depth analyses of the 
venom gland transcriptomes of helodermatid lizards to mine ‘enough’ nucleotide 
sequences for evolutionary selection analyses may shed light in this regard. 
Table 2. Relative toxin molecular evolutionary rates. 
Toxin Type Sequence pairs Estimates 
Kallikrein EU790962.1 (H. suspectum) vs. 
HM437246.1 (H. horridum) 
dN: 0.180; dS: 0.225; dN/dS: 0.80 
EU790963.1 (H. suspectum) vs. 
HM437246.1 (H. horridum) 
dN: 0.242; dS: 0.450; dN/dS: 0.53 
EU790962.1 (H. suspectum) vs. 
EU790963.1 (H. suspectum) 
dN: 0.081; dS: 0.173; dN/dS: 0.47 
Average dN: 0.167; dS: 0.282; dN/dS: 0.60 
CRiSP EU790958.1 (H. suspectum) vs. 
U13619.1 (H. horridum) 
dN: 0.011; dS: 0.022; dN/dS: 0.49 
Helofensin GQ918270.1 (H. suspectum) vs. 
EU790964.1 (H. suspectum) 
dN: 0.030; dS: 0.036; dN/dS: 0.84 
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GQ918271.1 (H. suspectum) vs. 
EU790964.1 (H. suspectum) 
dN: 0.052; dS: 0.065; dN/dS: 0.80 
GQ918271.1 (H. 
suspectum) vs. GQ918270.1 (H. 
suspectum) 
dN: 0.020; dS: 0.027; dN/dS: 0.74 
Average dN: 0.034; dS: 0.042; dN/dS: 0.80 
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Figure 5: Phylogenetic reconstruction of A) BPI-fold and B) semaphorin proteins. Previously known 
sequences are referred to by their uniprot accession codes while Heloderma suspectum sequences obtained 
in this study are referred to by their genbank codes. 
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Figure 6: Sequence alignment of A) the BPI-fold proteins from Heloderma suspectum venom (KP224275) 
and Anolis caronlinensis genome (R4GBN8) and B) the semaphorin proteins from Heloderma suspectum 
venom (KP224276) and Anolis caronlinensis genome (G1KSB1). 
Materials and Methods 
Venom collection 
Venoms were obtained from captive bred adult male specimens of Heloderma 
exasperatum (Rio Fuerte, Mexico founder stock), Heloderma horridum (Colima, Mexico 
founder stock) and Heloderma suspectum (Phoenix, Arizona founder stock).  
Shotgun sequencing 
In order to identify low molecular weight peptides that do not resolve well on 1D or 2D 
gels, shotgun sequencing was used. 3 µg of crude venom sample was dissolved in 50 µL 
of 100 mM ammonium carbonate to reduce and alkylate cysteine bonds with subsequent 
addition of 50 µL of 2% iodoethanol/0.5% triethylphosphine in acetonitrile. The sample was 
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afterwards resuspended in 20 µL of 40 mM ammonium bicarbonate, before overnight 
incubation (at 37 °C) with 750 ng of sequencing grade trypsin (Sigma-Aldrich). To stop 
digestion 1 µL of concentrated formic acid was added to each of the samples. Samples 
were lyophilised then resuspended in 20 µL of 5% ACN/0.5% FA, put into MS vials and 
subjected to LC–MS/MS analysis. 
One-dimensional gel electrophoresis 
In order to compare venom proteomes between species, 1D gradient gels were run under 
both reducing and non-reducing conditions using the manufacturer (BioRad) protocol. Gels 
were prepared as follows: 0.05 mL Milli-Q H2O, 2.5 mL 30% acrylamide mix, 1.5 mL 1.0 M 
Tris-HCl, pH 8.45, 0.48 glycerol, 20 µL 10% APS, 2 µL TEMED (spreading gel); 0.76 mL 
Milli-Q H2O, 0.76. mL 30% acrylamide mix, 0.76 mL 1.0 M Tris-HCl, pH 8.45, 15 µL 10% 
APS, 2 µL TEMED (spacer gel); 1.56 mL Milli-Q H2O, 0.34 mL 30% acrylamide mix, 0.63 
mL 1.0 M Tris-HCl, pH 8.45, 15 µL 10% APS, 2 µL TEMED (stacking gel). Spreading gel 
was cast first. After it set the spacer gel was slowly layered atop it, and after the spacer gel 
set the stacking gel was layered atop it. Running buffers were: 0.2 M Tris-HCl, pH 8.9 
(anode buffer); 0.1 M Tris-tricine-HCl pH 8,45. The gels were run at 100 V for three hours 
at room temperature. 30 µg of venom was reconstituted in Tricine loading buffer (Bio-Rad) 
with 10 mM DTT added to provide reduce conditions. Gels were stained overnight with 
colloidal Coomassie brilliant blue G250 (34% methanol, 3% phosphoric acid, 170 g/L 
ammonium sulphate, 1 g/L Coomassie blue G250). After the staining was complete, gels 
were destained using MilliQ water. 
Two-dimensional gel electrophoresis 
In order to further investigate the proteomics variation, particularly that of isoelectric 
variation, 2D gels were run. 0.3 mg of venom sample were solubilized in 125 µL of 
rehydration buffer (8 M urea, 100 mM DTT, 4% CHAPS, and 0.5% ampholytes (Biolytes 
pH 3–10, Bio-Rad Lab)) with 0.01% bromophenol blue. The sample was mixed with 
shaking and centrifuged for 5 min at 4 °C, 14, 000 rpm. This was done to remove any 
insoluble material. The supernatant was loaded onto IEF strips (Bio-Rad ReadyStrip, non-
linear pH 3–10, 7 cm IPG) and left overnight for passive rehydration. Protein focusing was 
achieved via PROTEAN i12 IEF CELL (Bio-Rad Lab). The IEF running conditions were as 
follows: 100 V for 1 h, 500 V for 1 h, 1,000 V for 1 h and 8,000 V until 98,400 V/h. Actual 
current in the final step of the run varied in accordance to resistance. To each strip a 
constant current of 50 µA was applied. After the run IPG strips were incubated for 10 min 
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in a reducing equilibration buffer (50 mM Tris–HCl, pH 8.8, 6 M urea, 2% SDS, 30% 
glycerol, 2% DTT) to reduce cysteine bonds. To alkylate reduced bonds IPG strips were 
further incubated for 20 min in an alkylating equilibration buffer (50 mM Tris–HCl, pH 8.8, 6 
M urea, 2% SDS, 30% glycerol, 2.5% iodoacetamide). After rinse with SDS-PAGE running 
buffer, IPG strips were positioned on top of 12% polyacrylamide gels (Protean-II Plus, 18 × 
20 cm, Bio-Rad Lab) using 0.5% agarose. Gels were run with a current of 10 mA/per gel 
for 20 min followed by 20 mA/per gel for the rest of the run until the bromophenol dye front 
was within 0.5 cm of the base of the gel. After the run, gels were briefly washed with water 
and stained with 0.2% colloidal Coomassie brilliant blue G250 overnight. Water was used 
to remove the excess of the dye after staining was complete. Visible spots were 
subsequently picked from gels and digested overnight at 37 °C with the use of sequencing 
grade trypsin (Sigma-Aldrich). Afterwards gel spots were washed with MiliQ water, 
destained (40 mM NH4CO3/50% acetonitrile (ACN)) and dehydrated (100% ACN); 
rehydration occurs in 10 µL of 20 µg/ml TPCK trypsin with subsequent incubation at 37 °C 
overnight. To elute peptides following solutions were used per each spot: 20 µL of 1% 
formic acid (FA), followed by 20 µL of 5% ACN/0.5% FA. Collected peptides were put into 
MS vials and subjected to LC–MS/MS analysis. 
LC–MS/MS 
In order to identify the toxin types present, digested gel spots and digested whole venom 
(shotgun) samples were processed using an Agilent Zorbax stable bond C18 column (2.1 
mm by 100 mm, 1.8 µm particle size, 300 Å pore size) at a flow rate of 400 µL per minute 
and a gradient of 1–40% solvent B (90% acetonitrile, 0.1% formic acid) in 0.1% formic acid 
over 15 minutes or 4 minutes for shotgun samples and 2D-gel spots respectively on a 
Shimadzu Nexera UHPLC coupled with an AB SCIEX 5600 Triple TOF mass 
spectrometer. MS2 spectra are acquired at a rate of 20 scans per second with a cycle time 
of 2.3 seconds and optimised for high resolution. Precursor ions were selected between 80 
and 1800 m/z with a charge state of 2–5 and of an intensity of at least 120 counts per 
second with a precursor selection window of 1.5 Da. The isotopes within 2 Da were 
excluded for MS2. MS2 spectra were searched against known translated transcriptome 
libraries or UniProt database with Proteinpilot v4.0 (ABSciex) using a thorough 
identification search, specifying iodoacetamide as an alkylation method, trypsin digestion 
and allowing for biological and chemical modifications (ethanolyl C or deamidated N in 
particular) and amino acid substitutions, including artefacts induced by the preparation or 
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analysis processes. This was done to maximize the identification of protein sequences. 
Spectra were inspected manually to eliminate false positives. 
Phylogenetic analysis and alignment 
We performed phylogenetic analyses in such a way so as to allow reconstruction of the 
molecular evolutionary history of each toxin type for which transcripts were 
bioinformatically recovered. We identified toxin sequences by comparison of the translated 
DNA sequences with previously characterised toxins using a BLAST search of the 
UniProtKB protein database. Molecular phylogenetic analyses of toxin transcripts were 
conducted using the translated amino acid sequences.  
In each dataset we included comparative sequences from other venomous reptiles and 
physiological gene homologs previously identified from non-venom gland transcriptomes to 
suit as outgroup sequences. All sequences obtained in this study are referred to by their 
Genbank accession numbers (http://www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) 
and sequences from previous studies are referred to by their UniProtKB accession 
numbers (www.uniprot.org).  
For sequence alignment we used CLC Mainbench. In sequence alignments, the leader 
sequence is shown in lowercase and cysteines are highlighted in black. > and < indicate 
incomplete N/5’ or C/3’ ends, respectively and * is used to indicate the end of a sequence. 
To analyse datasets we used Bayesian inference implemented on MrBayes, version 3.2.1 
using lset rates=invgamma with prset aamodelpr=mixed, which enables the program to 
optimize between nine different amino acid substitution matrices. The analysis was 
performed by running a minimum of 107 generations in four chains, and saving every 
100th tree. The log-likelihood score of each saved tree was plotted against the number of 
generations to establish the point at which the log likelihood scores reached their 
asymptote, and the posterior probabilities for clades established by constructing a 
majority-rule consensus tree for all trees generated after completion of the burn-in phase. 
Pairwise-estimation of dN/dS 
Pairwise-estimates of dN/dS were obtained for Heloderma Kallikreins, CRiSPs and lethal 
toxins using the Codeml program of PAML package.  
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Conclusion 
Due to the limited amount of previously available proteomic data, these results significantly 
contribute to our understanding of helodermatid lizard venoms. Despite the H. suspectum 
having been separated from all other extant species for 30 million years, the venoms have 
a significant overall level of similarity in regards to protein/peptide types present but with 
variable expression within these conserved classes. This suggesting that their venoms 
experienced a diversifying selection pressure different from that often governs the 
evolution of venom in other squamate reptiles such as snakes which display significant 
differences in the types of proteins expressed, even at low taxonomical levels. This 
variation pattern is likely a consequence of the fact that all helodermatid lizards intrinsically 
occupy the same ecological niche and thus feed upon the similar prey items. However, the 
discovery of novel components represents an exciting opportunity for biodiscovery and 
reinforces the basic premise that poorly investigated venomous lineages represent 
untapped resources of molecules with potential for utilization in drug design and 
development. 
References 
Ali, S. A., T. N. Jackson, N. R. Casewell, D. H. Low, S. Rossi, K. Baumann, B. Fathinia, J. 
Visser, A. Nouwens, I. Hendrikx, A. Jones, E. Undheim and B. G. Fry. "Extreme Venom 
Variation in Middle Eastern Vipers: A Proteomics Comparison of Eristicophis Macmahonii, 
Pseudocerastes Fieldi and Pseudocerastes Persicus." J Proteomics 116,  (2015): 106-13. 
Angulo, Y., J. Escolano, B. Lomonte, J. M. Gutierrez, L. Sanz and J. J. Calvete. "Snake 
Venomics of Central American Pitvipers: Clues for Rationalizing the Distinct Envenomation 
Profiles of Atropoides Nummifer and Atropoides Picadoi." J Proteome Res 7, no. 2 (2008): 
708-19. 
Beck, D. D. "Ecology and Behavior of the Gila Monster in Southwestern Utah." J Herpetol, 
(1990): 54-68. 
Beck, D. D. “Biology of Gila Monsters and Beaded Lizards”. Vol. 9: Univ of California 
Press, (2005). 
Bogert, C. M. "The Gila monster and its allies: the relationships, habits, and behavior of the 
lizards of the family Helodermatidae”. Bull Am Mus Nat Hist no. 109 (1956): 11–238. 
Boldrini-Franca, J., C. Correa-Netto, M. M. Silva, R. S. Rodrigues, P. De La Torre, A. 
Perez, A. M. Soares, R. B. Zingali, R. A. Nogueira, V. M. Rodrigues, L. Sanz and J. J. 
 77 
Calvete. "Snake Venomics and Antivenomics of Crotalus Durissus Subspecies from Brazil: 
Assessment of Geographic Variation and Its Implication on Snakebite Management." J 
Proteomics 73, no. 9 (2010): 1758-76. 
Bou-Abboud, C. F. and D. G. Kardassakis. "Acute Myocardial Infarction Following a Gila 
Monster (Heloderma Suspectum Cinctum) Bite." West J Med 148, no. 5 (1988): 577. 
Brust, A., K. Sunagar, E. A. Undheim, I. Vetter, D. C. Yang, N. R. Casewell, T. N. Jackson, 
I. Koludarov, P. F. Alewood, W. C. Hodgson, R. J. Lewis, G. F. King, A. Antunes, I. 
Hendrikx and B. G. Fry. "Differential Evolution and Neofunctionalization of Snake Venom 
Metalloprotease Domains." Mol Cell Proteomics 12, no. 3 (2013): 651-63. 
Calvete, J. J., E. Fasoli, L. Sanz, E. Boschetti and P. G. Righetti. "Exploring the Venom 
Proteome of the Western Diamondback Rattlesnake, Crotalus Atrox, Via Snake Venomics 
and Combinatorial Peptide Ligand Library Approaches." J Proteome Res 8, no. 6 (2009): 
3055-67. 
Calvete, J. J., P. Juárez and L. Sanz. "Snake Venomics. Strategy and Applications." J 
Mass Spectrom 42, no. 11 (2007): 1405-1414. 
Cantrell, F. L. "Envenomation by the Mexican Beaded Lizard: A Case Report." J Toxicol 
Clin Toxicol 41, no. 3 (2003): 241-4. 
Casewell, N. R., W. Wuster, F. J. Vonk, R. A. Harrison and B. G. Fry. "Complex Cocktails: 
The Evolutionary Novelty of Venoms." Trends Ecol Evol 28, no. 4 (2013): 219-29. 
Castro, E. N., B. Lomonte, M. del Carmen Gutierrez, A. Alagon and J. M. Gutierrez. 
"Intraspecies Variation in the Venom of the Rattlesnake Crotalus Simus from Mexico: 
Different Expression of Crotoxin Results in Highly Variable Toxicity in the Venoms of Three 
Subspecies." J Proteomics 87,  (2013): 103-21. 
Daltry, J. C., W. Wuster and R. S. Thorpe. "Diet and Snake Venom Evolution." Nature 379, 
no. 6565 (1996): 537-40. 
Douglas, M. E., M. R. Douglas, G. W. Schuett, D. D. Beck and B. K. Sullivan. 
"Conservation Phylogenetics of Helodermatid Lizards Using Multiple Molecular Markers 
and a Supertree Approach." Mol Phylogenet Evol 55, no. 1 (2010): 153-167. 
Drucker, D. J. and M. A. Nauck. "The Incretin System: Glucagon-Like Peptide-1 Receptor 
Agonists and Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes." Lancet 368, no. 9548 
(2006): 1696-705. 
Forstner, M. R. J., R. A. Hilsenbeck and J. F. Scudday. "Geographic Variation in Whole 
 78 
Venom Profiles from the Mottled Rock Rattlesnake (Crotalus Lepidus Lepidus) in Texas." J 
Herpetol, (1997): 277-287. 
French, W. J., W. K. Hayes, S. P. Bush, M. D. Cardwell, J. O. Bader and E. D. Rael. 
"Mojave Toxin in Venom of Crotalus Helleri (Southern Pacific Rattlesnake): Molecular and 
Geographic Characterization." Toxicon 44, no. 7 (2004): 781-91. 
Fry, B. G., J. C. Wickramaratna, W. C. Hodgson, P. F. Alewood, R. M. Kini, H. Ho and W. 
Wuster. "Electrospray Liquid Chromatography/Mass Spectrometry Fingerprinting of 
Acanthophis (Death Adder) Venoms: Taxonomic and Toxinological Implications." Rapid 
Commun Mass Spectrom 16, no. 6 (2002): 600-8. 
Fry, B. G., W. Wuster, R. M. Kini, V. Brusic, A. Khan, D. Venkataraman and A. P. Rooney. 
"Molecular Evolution and Phylogeny of Elapid Snake Venom Three-Finger Toxins." J Mol 
Evol 57, no. 1 (2003): 110-29. 
Fry, B. G., W. Wuster, S. F. R. Ramjan, T. Jackson, P. Martelli and R. M. Kini. "Analysis of 
Colubroidea Snake Venoms by Liquid Chromatography with Mass Spectrometry: 
Evolutionary and Toxinological Implications." Rapid Commun Mass Spectrom 17, no. 18 
(2003): 2047-62. 
Fry, B. G., H. Scheib, L. van der Weerd, B. Young, J. McNaughtan, S. F. Ramjan, N. Vidal, 
R. E. Poelmann and J. A. Norman. "Evolution of an Arsenal: Structural and Functional 
Diversification of the Venom System in the Advanced Snakes (Caenophidia)." Mol Cell 
Proteomics 7, no. 2 (2008): 215-46. 
Fry, B. G., K. Roelants, K. Winter, W. C. Hodgson, L. Griesman, H. F. Kwok, D. Scanlon, 
J. Karas, C. Shaw, L. Wong and J. A. Norman. "Novel Venom Proteins Produced by 
Differential Domain-Expression Strategies in Beaded Lizards and Gila Monsters (Genus 
Heloderma)." Mol Biol Evol 27, no. 2 (2010): 395-407. 
Fry, B. G., K. Winter, J. A. Norman, K. Roelants, R. J. Nabuurs, M. J. van Osch, W. M. 
Teeuwisse, L. van der Weerd, J. E. McNaughtan, H. F. Kwok, H. Scheib, L. Greisman, E. 
Kochva, L. J. Miller, F. Gao, J. Karas, D. Scanlon, F. Lin, S. Kuruppu, C. Shaw, L. Wong 
and W. C. Hodgson. "Functional and Structural Diversification of the Anguimorpha Lizard 
Venom System." Mol Cell Proteomics 9, no. 11 (2010): 2369-90. 
Gibbs, H. L. and S. P. Mackessy. "Functional Basis of a Molecular Adaptation: Prey-
Specific Toxic Effects of Venom from Sistrurus Rattlesnakes." Toxicon 53, no. 6 (2009): 
672-9. 
 79 
Gutierrez, J. M., L. Sanz, J. Escolano, J. Fernandez, B. Lomonte, Y. Angulo, A. Rucavado, 
D. A. Warrell and J. J. Calvete. "Snake Venomics of the Lesser Antillean Pit Vipers 
Bothrops Caribbaeus and Bothrops Lanceolatus: Correlation with Toxicological Activities 
and Immunoreactivity of a Heterologous Antivenom." J Proteome Res 7, no. 10 (2008): 
4396-408. 
Hooker, K. R., E. M. Caravati and S. C. Hartsell. "Gila Monster Envenomation." Ann 
Emerg Med 24, no. 4 (1994): 731-5. 
Lomonte, B., J. Escolano, J. Fernandez, L. Sanz, Y. Angulo, J. M. Gutierrez and J. J. 
Calvete. "Snake Venomics and Antivenomics of the Arboreal Neotropical Pitvipers 
Bothriechis Lateralis and Bothriechis Schlegelii." J Proteome Res 7, no. 6 (2008): 2445-57. 
Lopez-Lozano, J. L., M. V. de Sousa, C. A. Ricart, C. Chavez-Olortegui, E. Flores 
Sanchez, E. G. Muniz, P. F. Buhrnheim and L. Morhy. "Ontogenetic Variation of 
Metalloproteinases and Plasma Coagulant Activity in Venoms of Wild Bothrops Atrox 
Specimens from Amazonian Rain Forest." Toxicon 40, no. 7 (2002): 997-1006. 
Mackessy, S. P. "Venom Ontogeny in the Pacific Rattlesnakes Crotalus Viridis Helleri and 
C. V. Oreganus." Copeia,  (1988): 92-101. 
Mackessy, S. P. "Evolutionary Trends in Venom Composition in the Western Rattlesnakes 
(Crotalus Viridis Sensu Lato): Toxicity Vs. Tenderizers." Toxicon 55, no. 8 (2010): 1463-
74. 
Miller, M. F. "Gila Monster Envenomation." Ann Emerg Med 25, no. 5 (1995): 720. 
Pawlak, J., S. P. Mackessy, N. M. Sixberry, E. A. Stura, M. H. Le Du, R. Menez, C. S. Foo, 
A. Menez, S. Nirthanan and R. M. Kini. "Irditoxin, a Novel Covalently Linked Heterodimeric 
Three-Finger Toxin with High Taxon-Specific Neurotoxicity." FASEB J 23, no. 2 (2009): 
534-45. 
Pianka, E. R., D. K. and R. A. King. “Varanoid Lizards of the World”. Bloomington, Indiana 
University Press, (2004). 
Reiserer, R. S., G. W. Schuett and D. D. Beck. "Taxonomic Reassessment and 
Conservation Status of the Beaded Lizard, Heloderma Horridum (Squamata: 
Helodermatidae)." Amphib. Reptile Conserv 7,  (2013): 74-96. 
Salazar, A. M., B. Guerrero, B. Cantu, E. Cantu, A. Rodriguez-Acosta, J. C. Perez, J. A. 
Galan, A. Tao and E. E. Sanchez. "Venom Variation in Hemostasis of the Southern Pacific 
Rattlesnake (Crotalus Oreganus Helleri): Isolation of Hellerase." Comp Biochem Physiol C 
 80 
Toxicol Pharmacol 149, no. 3 (2009): 307-16. 
Sanz, L., J. Escolano, M. Ferretti, M. J. Biscoglio, E. Rivera, E. J. Crescenti, Y. Angulo, B. 
Lomonte, J. M. Gutierrez and J. J. Calvete. "Snake Venomics of the South and Central 
American Bushmasters. Comparison of the Toxin Composition of Lachesis Muta Gathered 
from Proteomic Versus Transcriptomic Analysis." J Proteomics 71, no. 1 (2008): 46-60. 
Sanz, L., H. L. Gibbs, S. P. Mackessy and J. J. Calvete. "Venom Proteomes of Closely 
Related Sistrurus Rattlesnakes with Divergent Diets." J Proteome Res 5, no. 9 (2006): 
2098-112. 
Strimple, P. D., A. J. Tomassoni, E. J. Otten and D. Bahner. "Report on Envenomation by 
a Gila Monster (Heloderma Suspectum) with a Discussion of Venom Apparatus, Clinical 
Findings, and Treatment." Wilderness Environ Med 8, no. 2 (1997): 111-6. 
Sunagar, K., W. E. Johnson, S. J. O'Brien, V. Vasconcelos and A. Antunes. "Evolution of 
Crisps Associated with Toxicoferan-Reptilian Venom and Mammalian Reproduction." Mol 
Biol Evol 29, no. 7 (2012): 1807-22. 
Sunagar, K., E. A. Undheim, H. Scheib, E. C. Gren, C. Cochran, C. E. Person, I. 
Koludarov, W. Kelln, W. K. Hayes, G. F. King, A. Antunes and B. G. Fry. "Intraspecific 
Venom Variation in the Medically Significant Southern Pacific Rattlesnake (Crotalus 
Oreganus Helleri): Biodiscovery, Clinical and Evolutionary Implications." J Proteomics 99,  
(2014): 68-83. 
Tashima, A. K., L. Sanz, A. C. Camargo, S. M. Serrano and J. J. Calvete. "Snake 
Venomics of the Brazilian Pitvipers Bothrops Cotiara and Bothrops Fonsecai. Identification 
of Taxonomy Markers." J Proteomics 71, no. 4 (2008): 473-85. 
Wagstaff, S. C., L. Sanz, P. Juarez, R. A. Harrison and J. J. Calvete. "Combined Snake 
Venomics and Venom Gland Transcriptomic Analysis of the Ocellated Carpet Viper, Echis 
Ocellatus." J Proteomics 71, no. 6 (2009): 609-23.  
 81 
Chapter 3. Taming the dragon: investigating 
evolutionary forces that shape the complexity of 
monitor lizards’ venom  
 82 
Taming the dragon: investigating evolutionary forces that shape the 
complexity of monitor lizards’ venom 
Abstract 
For almost a century the intriguing consequences of the Komodo dragon’s bite have 
demanded a thorough scientific investigation. Several hypotheses have been proposed 
and a mounting pile of evidence indicates that the oral glands of varanid lizards secrete 
various toxins homologous to those of venomous snakes. Here we present a first broad 
scale investigation into the composition of varanid lizard venom, and compare proteomic 
and bioactivity data with published reports of monitor lizard ecology. Our results not only 
reveal the remarkable complexity of varanid lizard venom, but are also indicative of a 
tripartite relationship between their venom content, size and habitat. Altogether, our 
findings portray Varanus oral secretions as a multifunctional tool, likely to play an active 
role in either defence, predation or digestion, or perhaps a combination of these. 
Introduction 
Monitors, varanid lizards or goannas are mostly carnivorous squamate reptiles belonging 
to the genus Varanus. Their body size ranges from 23 cm for the adult V. brevicauda to 
over 3 m for V. komodoensis and they occupy diverse habitats throughout Africa, Asia and 
Australia, with the latter having the highest number of varanid species, apparently due to 
the lack of indigenous placental predators (Sweet and Pianka, 2007; Pianka and King, 
2004). 
Varanid lizards belong to the lizard clade Anguimorpha that also contains anguid lizards 
and helodermatids of which the gila monster is the most well-known species (Pyron et al., 
2013, Vidal et al., 2012; Reeder et al., 2015). The closest extant relative of Varanus is the 
Borneo earless monitor Lanthanotus borneensis, also included in this study. 
Despite their unique appearance as giant terrestrial reptiles and stories that blow their 
notoriety out of proportion (Auffenberg, 1981), for a long time only scant scientific 
information was available on the basic ecology, feeding behaviour, anatomy and 
physiology of varanid lizards. Only relatively recently have varanid lizards started to get 
attention they deserve. 
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In the 21st century studies on monitor lizard diets (Guarino, 2001), foraging behaviour 
(Guarino, 2002), shape variation (Collar et al., 2011; Openshaw and Keogh, 2014), bite 
force (D'Amore et al., 2011; Fry et al 2009), movement strategies and others began to 
form the basis of scientific understanding of Varanus. However, these studies were largely 
biased towards easily accessible species that spend most of their adult life on the ground, 
leaving out cryptic arboreal species. 
At the same time, studies demonstrating the uniqueness of varanid oral glands began to 
appear. Morphological studies by Elazar Kochva revealed similarities between Heloderma 
and Varanus glands and put them on continuum with anguid lizard glands, naming them 
“glands of Gabe” (Kochva, 1978). Further studies revealed that the oral glands of the 
Komodo dragon are of sophisticated structure with separated protein and mucus parts, 
structured lumen and a thick membranous cover (Fry et al., 2010a,b). 
Morphological as well as molecular evolutionary studies suggested that these glands are 
homologous not only to Heloderma venom glands, but also to the venom glands of front-
fanged snakes (Vidal and Hedges, 2005; Fry et al., 2006, 2009b,c 2010a). At the same 
time it was shown that within the Anguimorpha complex oral glands are relatively 
uncommon. Only beaded lizards (Heloderma) and monitors (Varanus and Lanthanotus) 
have independently evolved complex oral secretory apparatus, with others mostly having 
simple-structured glands. 
On the other hand anecdotal data on complications following Komodo dragon bites 
triggered scientific interest and was at first explained via the potential of pathogenic 
bacteria unique to the lizards’ oral flora. The origin of this idea dates back to folk myths, 
however Auffenberg is often quoted as the originator of it. In his monumental 1981 study 
he reports the presence of Staphylococcus sp., Providencia sp., Proteus morgani and 
Proteus mirabilis in mucoid samples from the external gum surface of the upper jaw of two 
freshly captured “oras” (the local name for Komodo dragon). In the same study, the 
specimen from the San Diego Zoo possessed none of these bacteria, allowing for the 
conclusion that oras may depend on frequent reinfestation from carrion to replenish their 
“weaponised bacteria”. Though Auffenberg admits that Proteus-dominated infection could 
be responsible for the consequences of some of the recorded bites and could potentially 
play an adaptive role in Komodo dragon ecology, he himself concludes “that the infectious 
feature of an ora bite is a folk myth” (Auffenberg, 1981).  
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It was not until very recently, however, that the idea was definitively discarded, since 
Komodo dragon oral flora turned out to be not at all dissimilar from that of any other 
carnivorous animal (Goldstein et al., 2013).  
By that time, multiple phylogenetic studies had reassessed morphology-based 
classifications of squamate reptiles and positioned anguimorph lizards in a clade with 
Iguania and Serpents (Vidal and Hedges 2005, 2009; Fry et al., 2006). The clade was 
given the name “Toxicofera” to reflect the presence of toxin-secreting oral glands as one of 
the defining synapomorphies of the group. Genetic studies further corroborated close 
evolutionary relationships between snakes and anguimorph lizards, showing that 
Anguimorpha oral glands express proteins homologous to toxins found in the venom of 
front-fanged snakes (Fry et al., 2010b). 
Such toxin groups as kallikrein, CRiSP, natriuretic peptides and phospholipase A2 type III 
have been recovered from varanid lizard venom gland transcriptomes (Fry et al., 2006, 
2010b), some of which might be responsible for the hypotensive effect of the crude venom 
intravenous injections in rats (Fry et al., 2006). 
Recent reports of human envenomations by monitor lizards seem to be inconclusive as to 
whether their bite possesses any threat to human health other than pure mechanical 
damage. Vikrant and Verma report a lethal bite by Varanus bengalensis that induced local 
pain, blood loss, as well as nausea, diaphoresis, dizziness, and breathlessness in victim 
and eventually led to an acute kidney injury and cardiac arrest (Vikrant and Verma, 2014); 
however, the actual culprit responsible for this bite has been questioned by clinical 
toxinologists (Weinstein and White, 2015). In contrast, Ducey et al. report a bite by a 
juvenile Komodo Dragon that led to faintness, prolonged bleeding and transient 
hypotension that the authors attributed to a vasovagal reaction (Ducey et al., 2016). 
Eventually, the only lasting effect of the bite was numbness in the finger where the 
monitor’s tooth had been retained after the bite. Obviously, these two incidents cannot be 
properly compared due to the species differences as well as age of the lizards. 
Anecdotally, a great many varanid lizard bites to biologists, zookeepers and amateur 
reptile enthusiasts have resulted in little that could be attributed to the action of toxins; 
however, some bite victims do report burning sensations and inflammation 
disproportionate the the mechanical damage inflicted (Sweet 2016). 
When compared with much better studied gila monster bites, one clear aspect of 
difference becomes apparent: a helodermatid lizard will stay attached, continuously 
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chewing in more venom into the bite site, while a monitor lizard is unlikely to hold onto 
something that is not a food item. This obviously should lead to difference in amount of 
oral fluids administered to the victim. Interestingly, while feeding on large prey items, 
varanid lizards seem to have a tendency to shake it violently, prompting subjugation (Loop, 
1974). 
Given that both varanid and helodermatid venom glands are the most developed within the 
Anquimorpha, and that a number of studies have revealed remarkable complexity and 
medical potential of Heloderma venom (Ma et al., 2011; Furman, 2012; Irwin, 2012), it 
became a point of interest to study the venom system of varanid lizards in detail. 
The evolution of a complex venom system is likely only possible under certain contingent 
circumstances –  i.e., when both environmental conditions select for it and a species’ 
overall evolutionary trajectory facilitates it. For example, in Iguania the incipient venom 
glands never developed any significant complexity probably due to the mainly 
insectivorous/herbivorous nature of these lizards. In addition, in at least some cases when 
animal develops a method of subduing prey that renders the venom system excessive, or 
switches to defenceless prey, the system degrades – as seen in numerous snake species 
(Fry et al., 2012). The cost of venom production is presumably high enough to justify the 
presence of active secretory and delivery apparatuses only when it is contributing to a 
functional role in the life of the organism (Morgenstern and King, 2013). 
The fact that varanid lizards possess highly developed oral glands suggests that those 
glands in one way or another play an important role in their life. They may have functions 
different to that of aiding in subjugation of prey: they may help in digestion, providing 
specific enzymes, or aid in maintaining oral health by secreting antimicrobial agents. And 
even if they are indeed toxin-secreting glands, those toxins might not be necessarily for 
prey capture, they may be equally important in defence against predators (Arbuckle, 
2009). 
It goes without saying that no varanid lizard would rely entirely on its venom (if it indeed is 
venomous) for subduing its prey, and the role of this hypothetical venom would be 
remarkably different to that which it plays in the lives of most venomous snakes. The 
remarkable speed at which monitors charge at food items, their sharp teeth and claws all 
seem to guarantee a successful meal. However, no predator will have a 100% success 
rate in hunting, so a system that can increase this rate even by a margin will be selected 
for – as long as its benefits outweigh its costs. 
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All monitor lizards share the same morphological features; their body shape scales 
allometrically with only minor exceptions that we mention below (Collar et al., 2011; 
Openshaw and Keogh, 2014; Thompson et al., 2009). Given how plastic the body plan 
generally is in reptiles and how easily it is shaped by changes in habitat and diet, it does 
not seem to be a coincidence that all varanid lizards rely on more or less the same 
strategy for securing a meal – the strategy appears to work remarkably well. 
The strategy in question seems to be “eat everything you can grab”. That might be the 
reason why varanid lizards tend to occupy any carnivorous niche the conditions allow for 
and only cold climate and carnivorous placental mammals can hinder their progress. Some 
monitors function as an entire predator guild, undergoing an ontogenetic niche shift from 
being strictly arboreal in juvenile stage all the way to strictly terrestrial when they are adults 
(Purwandana et al., 2016). At the same time, monitor lizards also scavenge a lot – from 
carrion to even fruit in some species (Pianka and King, 2004). Both of these strategies 
benefit from monitor’s stamina and chemosensory apparatus as well as “bite and tear” 
build. That means that habitat will affect monitor’s diet in two ways – directly, by providing 
prey items of specific type and indirectly, by putting constraints on size. 
Given all of that, if oral secretions are evolutionarily important for varanid lizards we would 
expect to see some tripartite relationship between size, habitat and oral secretion 
composition. 
A previous study (Fry et al., 2010b) revealed the presence of kallikrein transcripts in 
venom gland transcriptome of varanid lizards. Toxicoferan venom kallikreins are known for 
inducing fibrinogen depletion in the prey organism and thus prompting prolonged bleeding 
(see Chapter 1 for more information on toxic functions of kallikreins). It is not 
unforeseeable that, if given a chance, a predator would benefit from inducing blood loss or 
altering blood pressure in its prey, for this will increase the chance of successful 
subjugation by weakening the prey. However, in the case of some monitor lizards, in 
particular the big species like the lace monitor (Varanus varius) or Komodo dragon, this 
type of toxic action might be beneficial even if a prey manages to escape the intial attack 
but succumbs to blood loss in the aftermath. Big monitors are known for relying on 
scavenging to the point that for some of them carrion can be considered a staple food item 
(Guarino, 2001), and in most areas these species inhabit, they are one of the most if not 
the most prominent scavengers (Auffenberg, 1981; Pascoe et al., 2011; Pianka and King, 
2004). At the same time they are known to have wide foraging areas (Guarino, 2002) and 
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to be capable of tracking food items (especially carrion) from miles away due to their 
extremely refined chemosensory apparatus (Auffenberg, 1981; Pianka and King, 2004; 
Guarino, 2002). Given all of that and the tendency to bite everything that looks like a prey 
item, a scenario in which a victim escapes but subsequently succumbs to blood loss will 
be beneficial for the monitor lizard. 
Of course, all of that does not mean that aiding in scavenging is the primary role of venom 
in big varanid lizards, but it helps to illustrate the point that even slow-acting venom will still 
have a positive impact on the monitor’s wellbeing, playing into both of the feeding 
strategies. In order to be selected for and maintained, this hypothetical venom system 
would not have to be a nuclear arsenal aimed to kill the victim on instant, it would only 
have to give the lizards’ hunting techniques a certain edge (Jackson and Fry, 2016). 
In the present study we used a number of proteomic techniques to reveal the complexity 
and content of oral secretion from representative monitor species (Table 1). In addition we 
screened for a key bioactivities that might be reflective of the role these secretions play in 
the dietary ecology of monitor lizards. 
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Table 1. Species studied. 
Code Species Clade Habitat Diet Total Length 
ACA Varanus acanthurus Odatria 
Rocky areas 
throughout northern 
Australia, except 
eastern 
Queensland. 
Invertebrates like 
grasshoppers and 
beetles, also takes skinks 
and geckoes 
60 to 78 cm 
BAR Varanus baritji Odatria 
Rocky outcrops and 
stony hills with wild 
vegetation in the 
extreme parts of 
Northern Territory 
from the Adelaide 
River district east to 
near Borroloola. 
The species is poorly 
studied, but is closely 
related to V. acanthurus 
and is likely to be similar 
in feeding behaviour 
60 to 72 cm. 
GIG Varanus giganteus gouldii 
Arid inland from 
western 
Queensland to the 
coastal areas of 
Western Australia. 
Feeds on anything it can 
overpower: reptiles, birds 
and mammals 
150 to 250 
cm. 
GIL Varanus gilleni Odatria 
Dried parts of inland 
Australia, mostly in 
Acacia, Casuarina 
and Eucapyptus 
woodlands. 
Wide range of prey items: 
arthropods, lizards, bird 
eggs and small mammals 
34 to 40 cm. 
GRI Varanus griseus African 
Sand dunes, clay 
steppes, riverbeds 
and other mostly 
arid and semiarid 
areas from Rio De 
Oro throughout the 
Sahara desert, to 
Egypt and northern 
Sudan, Arabian 
peninsula, central 
Asian deserts, 
Pakistan and 
northwestern India 
Mainly rodents, snakes 
and agamid lizards. 
Large arthropods are 
hunted intensively only 
when vertebrate prey is 
scarce. Egs and chicks 
are frequently eaten. 
120 to 150 
cm. 
JOB Varanus jobiensis Indo-Asian B 
Mixed alluvium and 
hill forests of New 
Guinea. Terrestrial 
and arboreal, seeks 
refuge by climbing 
trees. 
Tarantulas, insects, frogs 
and reptile eggs. Most 
prey items are insects. 
Can also eat fish or 
shrimps. 
up to 120 cm. 
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KOM Varanus komodoensis varius 
Monsoon forests, 
grasslands, 
savannas and 
mangrove forests of 
Komodo, Rinca, Gili 
Dasami, Flores and 
other islands in 
Indonesia. 
Hatchlings are 
arboreal, juveniles 
and subadults are 
both arboreal and 
terrestrial. Adults 
are strictly 
terrestrial. 
Juveniles are active 
predators, adults ambush 
their prey. Diet includes 
insects, bird and sea 
turtle eggs, carrion and 
small to large 
vertebrates: lizards, 
snakes, rodents, 
monkeys, wild boars, 
deer and water buffalo. 
up to 300 cm. 
MEL Varanus melinus Indo-Asian B 
Sawmps and 
tropical forests of 
Sula islands 
Insects, birds's eggs, tree 
frogs, potentially prawns 
and fish. 
120-150 cm 
MER Varanus mertensi gouldii 
Tropical northern 
Australia near 
water, from 
Kimberly to Cape 
York Peninsula. 
Water invertebrates, fish, 
frogs, turtle eggs, lizards 
and small mammals 
110 to 130 
cm. 
MIT Varanus mitchelli Odatria 
Northern Australia, 
from Kimberley 
region to extreme 
north-western 
Queensland in 
habitats with 
permanent or semi-
permanent water. 
Fish, frogs, invertebrates, 
crabs, reptile and their 
eggs, small mammals 
and birds 
60 to 96 cm. 
PRA Varanus prasinus Indo-Asian B 
Mostly highly 
arboreal. Monsoon, 
rain and palm 
forests, mangrove 
swamps and coca 
plantations of 
mainland New 
Guinea. 
Mostly insects. 
Occasionally spiders and 
rodents. 
up to 85 cm 
RUB 
Varanus 
panoptes 
rubidus 
gouldii 
Coastal and inland 
Western Australia in 
a variety of habitats 
with the preference 
for sandy or stony 
soils 
Preys on virtually 
anything it can 
overpower: insects, small 
mammals, reptiles, frogs, 
eggs 
120 to 160 
cm. 
SAL Varanus salvadorii varius 
Delta estuaries of 
big rivers in 
southern New 
Guinea. Arboreal 
and terrestrial. 
Little known. Belived to 
eat deer, pigs (hauled 
into canopy and eaten 
there), insects, lizards, 
birds, mammals. No 
precise information. 
up to 250 cm. 
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SCA Varanus scalaris Odatria 
Mostly woodland, as 
well as subhumid 
and humid 
rainforest habitats 
from Kimberley 
region to the far 
north-eastern 
coastal 
Queensland. 
Invertebrates, small 
skinks, geckoes, frogs, 
bird eggs and fledglings 
55 to 60 cm. 
TRI Varanus tristis Odatria 
Wide range of 
habitats all over 
Australia except 
some parts of south 
and south east. 
Lizards, invertebrates, 
birds and their eggs 60 to 80 cm. 
VAR Varanus varius varius 
Forested areas from 
the north-eastern 
coast of 
Queensland through 
coastal and inland 
New South Wales to 
Victoria and South 
Australia 
Preys on everything it 
can overpower 
150 to 200 
cm. 
 
Materials and Methods 
Milking 
Venoms and tissues were collected by A/Prof Fry. Specimens were milked into sterile jars. 
In order to remove mucous, all samples were filtered through 0.2 micron syringe filters 
prior to lyophilisation. 
1D gel electrophoresis 
In order to establish the proteomics variation, 1D gradient gels were run under both 
reducing and non-reducing conditions using the manufacturer (BioRad) protocol.  
Gels were prepared as follows: 0.05 mL Milli-Q H2O, 2,5 mL 30% acrylamide mix, 1.5 mL 
1.0 M Tris-HCl, pH 8.45, 0.480 glycerol, 20 µL 10% APS, 2 µL TEMED (spreading gel); 
0.760 mL Milli-Q H2O, 0.760 mL 30% acrylamide mix, 0.760 mL 1.0 M Tris-HCl, pH 8.45, 
15 µL 10% APS, 2 µL TEMED (spacer gel); 1.560 mL Milli-Q H2O, 0.340 mL 30% 
acrylamide mix, 0.630 mL 1.0 M Tris-HCl, pH 8.45, 15 µL 10% APS, 2 µL TEMED 
(stacking gel). 
Spreading gel was cast first. After it was set the spacer gel was slowly layered atop of it, 
and after spacer gel was set the stacking gel was layered atop of it. Running buffers were: 
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0.2 M Tris-HCl, pH 8,9 (anode buffer); 0.1 M Tris-tricine-HCl pH 8,45. The gels were run at 
100 V for three hours at room temperature. 
30 µg of venom was reconstituted in Tricine loading buffer (Bio-Rad) with 10 mM DTT 
added to provide reduce conditions. 
Gels were stained overnight with colloidal Coomassie brilliant blue G250 (34% methanol, 
3% phosphoric acid, 170 g/L ammonium sulphate, 1 g/L Coomassie blue G250). After the 
staining was complete, water was used to remove excess of the dye. 
2D gel electrophoresis 
In order to further investigate the proteomics variation, particularly that of isoelectric 
variation, 2D gels will be run using protocols previously optimised in the Fry lab (Ali et al., 
2013, Low et al., 2013). 0.3 mg (7 cm gels) and 2 mg (17 cm gel) of venom sample were 
solubilized in 125 µL (7 cm gels) and 1 ml (17 cm gels) of rehydration buffer (8 M urea, 
100 mM DTT, 4% CHAPS, and 0.5% ampholytes (Biolytes pH 3–10, Bio-Rad Lab)) with 
0.01% bromophenol blue. The sample was mixed with shaking and centrifuged for 5 min at 
4 °C, 14 000 rpm. This was done to remove any insoluble material. 
The supernatant was loaded onto IEF strips (Bio-Rad ReadyStrip, non-linear pH 3–10, 7 
cm and 17 cm IPG) and left overnight for passive rehydration. Protein focusing was 
achieved via PROTEAN i12 IEF CELL (Bio-Rad Lab). The IEF running conditions were as 
follows: 100 V for 1 h, 500 V for 1 h, 1000 V for 1 h and 8000 V until 98,400 V/h. Actual 
current in the final step of the run varied in accordance to resistance. To each strip a 
constant current of 50 µA was applied. After the run IPG strips were incubated for 10 min 
in a reducing equilibration buffer (50 mM Tris–HCl, pH 8.8, 6 M urea, 2% SDS, 30% 
glycerol, 2% DTT) to reduce cysteine bonds. To alkylate reduced bonds IPG strips were 
further incubated for 20 min in an alkylating equilibration buffer (50 mM Tris–HCl, pH 8.8, 6 
M urea, 2% SDS, 30% glycerol, 2.5% iodoacetamide). After rinse with SDS-PAGE running 
buffer, IPG strips were positioned on top of 12% polyacrylamide gels (Protean-II Plus, 18 × 
20 cm, Bio-Rad Lab) using 0.5% agarose. 
Gels were run at 4 °C with a current of 10 mA/per gel for 20 min followed by 20 mA/per gel 
for the rest of the run until the bromophenol dye front was within 0.5 cm of the base of the 
gel. After the run, gels were briefly washed with water and stained with 0.2% colloidal 
Coomassie brilliant blue G250 overnight. Water was used to remove the excess of the dye 
after staining was complete. 
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Visible spots were subsequently picked from gels and digested overnight at 37 °C with the 
use of sequencing grade trypsin (Sigma-Aldrich). 
Afterwards gel spots were washed with MiliQ water, destained (40 mM NH4CO3/50% 
acetonitrile (ACN)) and dehydrated (100% ACN); rehydration occurs in 10 µL of 20 µg/ml 
TPCK trypsin with subsequent incubation at 37 °C overnight. To elute peptides following 
solutions were used per each spot: 20 µL of 1% formic acid (FA), followed by 20 µL of 5% 
ACN/0.5% FA. Collected peptides were put into MS vials and subjected to LC–MS/MS 
analysis. 
Shotgun sequencing 
In order to identify low molecular weight peptides that do not resolve well on 1D or 2D 
gels, shotgun sequencing was used. 3 µg of crude venom sample was dissolved in 50 µL 
of 100 mM ammonium carbonate to reduce and alkylate cysteine bonds with subsequent 
addition of 50 µL of 2% iodoethanol/0.5% triethylphosphine in acetonitrile. The sample was 
afterwards resuspended in 20 µL of 40 mM ammonium bicarbonate, before overnight 
incubation (at 37 °C) with 750 ng of sequencing grade trypsin (Sigma-Aldrich). To stop 
digestion 1 µL of concentrated formic acid was added to each of the samples. Samples 
were lyophilised then resuspended in 20 µL of 5% ACN/0.5% FA, put into MS vials and 
subjected to LC–MS/MS analysis. 
LC–MS/MS 
In order to identify the toxin types present, digested gel spots and digested whole venom 
(shotgun) samples were processed using an Agilent Zorbax stable bond C18 column (2.1 
mm by 100 mm, 1.8 µm particle size, 300 Å pore size) at a flow rate of 400 µL per minute 
and a gradient of 1–40% solvent B (90% acetonitrile, 0.1% formic acid) in 0.1% formic acid 
over 15 minutes or 4 minutes for shotgun samples and 2D-gel spots respectively on a 
Shimadzu Nexera UHPLC coupled with an AB SCIEX 5600 Triple TOF mass 
spectrometer. MS2 spectra are acquired at a rate of 20 scans per second with a cycle time 
of 2.3 seconds and optimised for high resolution. Precursor ions were selected between 80 
and 1800 m/z with a charge state of 2–5 and of an intensity of at least 120 counts per 
second with a precursor selection window of 1.5 Da. The isotopes within 2 Da were 
excluded for MS2. MS2 spectra were searched against known translated transcriptome 
libraries or UniProt database with Proteinpilot v4.0 (ABSciex) using a thorough 
identification search, specifying iodoacetamide as an alkylation method, trypsin digestion 
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and allowing for biological and chemical modifications (ethanolyl C or deamidated N in 
particular) and amino acid substitutions, including artefacts induced by the preparation or 
analysis processes. This was done to maximize the identification of protein sequences. 
Spectra were inspected manually to eliminate false positives. 
Bioactivity studies 
Phsopholipase A2 activity 
We assessed the continuous phospholipase A2 (PLA2) activity of the venoms using a 
fluorescence substrate assay (EnzChek® Phospholipase A2 Assay Kit, ThermoFisher 
Scientific). A working stock solution of freeze dried venom was reconstituted in a buffer 
containing 50% MilliQ/50% glycerol (99.9%, Sigma) at a 1:1 ratio to preserve enzymatic 
activity and reduce enzyme degradation with the final venom concentration of 0.1 mg/ml, 
and then stored at -20°C. Venom solution (0.1 µg in dry venom weight) was brought up to 
12.5 µl in 1X PLA 2 reaction buffer (250 mM Tris-HCL, 500 mM NaCl, 5 mM CaCl 2, pH 
8.9) and plated out in triplicates on a 384 well plate. Triplicates were measured by adding 
12.5 µL quenched 1mM EnzChek® Phospholipase A2 substrate per well (total volume 
25µL/well) over 100 cycles at an excitation of 485 nm and emission of 520 nm, using a 
Fluoroskan Ascent (ThermoFisher Scientific). The negative control consisted of PLA 2 
reaction buffer and substrate only.  
Matrix mettaloprotease and kallikrein activity 
A working stock solution of freeze dried venom was reconstituted in a buffer containing 
50% MilliQ/50% glycerol (>99.9%, Sigma) at a 1:1 ratio to preserve enzymatic activity and 
reduce enzyme degradation with the final venom concentration of 0.1 mg/ml, and then 
stored at -20°C. Venom solutions (1 µg in dry venom weight) were plated in triplicates on a 
384 well plate and measured by adding 90µL quenched fluorescent substrate per well 
(total volume 100µL/well; 10µL/5mL enzyme buffer - 150 mM NaCl and 50 mM Tri-HCl pH 
7.3, Fluorogenic Peptide Substrate, R & D systems, Cat#ES001 & ES011, Minneapolis, 
Minnesota). Fluorescence was monitored (Cat#ES001 excitation at 320 nm and emission 
at 405 nm; Cat#ES011 excitation at 390 nm and emission at 460 nm) over 400 min or until 
activity has ceased.  
Rat ileum organ bath testings 
The rat ileum muscle preparations were isolated from adult male rats. The rats were killed 
by CO2 asphyxiation. The isolated preparations were individually mounted in 15 ml parallel 
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organ baths containing a Krebs solution with the following constituents (mM): NaCl, 118.4; 
KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 2.5; NaHCO3, 25 and glucose, 11.1). The 
Krebs solution was continuously bubbled with carbogen (95% O2 and 5% CO2) to 
maintain a pH between 7.2-7.4 at a temperature of 32-34°C. A resting tension between 1 
and 3g was found to be the optimal starting baseline.  
Stimulation was performed with 200 μg/ml of crude venom; Milli-Q H2O (170 μl) was used 
as a control. The venom was left in the organ bath with the preparation for approximately 
30 minutes or until the twitch response was completely abolished.  
Results and Discussion 
1D PAGE results (fig. 1-3) revealed differential complexity of oral secretion within the 
genus. Compared to the published results on Heloderma venom, which shows little 
variation across the genus (cf: Chapter 2), this data is suggestive of the differential role 
oral secretion plays in different varanid species and that it is evolving under selection 
pressure. 
2D PAGE results (fig. 4-8) further elucidated the clear differences in venom complexity 
across the genus. V. mertensi (fig. 5) has the most streamlined profile, with essentially a 
single acidic protein group of approximately 40 kDa, whereas the most complex profile 
recovered is that of V. varius (fig. 7) with various protein groups dispersed all across 
molecular weight range and pI gradient. All other species profiles form a continuum of 
complexity between the two. The 40 kDa acidic protein group is present in all specimens 
with the sole exception of V. griseus (fig. 7) which exhibits a 2D profile with only a few low-
molecular weight protein groups. Several profiles exhibit a specific pattern usually 
indicative of different isoforms of the same protein (most likely due to difference in 
glycosylation), and this is especially notable in the V. salvadorii profile (fig. 7). 
MS-analysis of excised gel spots revealed that while different, all venoms but that of V. 
griseus are mainly composed of kallikrein and CRiSP proteins – the approximately 40 kDa 
spot in the acidic region. This finding was further corroborated by crude venom MS that 
portrayed varanid oral secretion as largely based on kallikrein, CRiSP, lysosomal acid 
lipase, phospholipase A2 and natriuretic peptides, with individual species and phylogenetic 
groups having their unique components (fig. 9). Altogether more than 20 different protein 
classes were recovered in oral secretion of studied species, all of which have the potential 
to play a functional role in defence or feeding (including predation and scavenging). 
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CRiSP toxins are reported to have various channel-blocking activities resulting in smooth 
muscle paralysis and hypothermia. Toxicoferan venom kallikreins increase vascular 
permeability and reduce blood pressure as well as stimulating inflammation and blood loss 
through fibrinogenolysis. Toxic natriuretic peptides also induce hypotension, while PLA2 
block platelet aggregation (Fry, 2015). 
On the other hand, chitinase and chitotriosidase have a well-defined function of cleaving 
chitin, which might potentially play a role in digestion of arthropods as well as provide 
defence against chitin-coated pathogens such as Plasmodium or Cryptococcus (Hamid et 
al., 2013). 
   
Figure 1. 1D PAGE reduced results. MER – V. mertensi, GIG – V. giganteus, RUB – V. panoptes rubidus, 
MIT – V. mitcheli, SCA – V. scalaris, TRI – V. tristis, GIL – V. gilleni, ACA – V. acanthurus, BAR – V. baritji. 
LAL – Lysosomal acid lipase, KLK – kallikrein. 
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Figure 2. 1D PAGE reduced results. GRI – V. griseus, PRA – V. prasinus, JOB – V. jobiensis, MEL – V. 
melinus, SAL – V. salvadorii, VAR – V. varius, HS – H. suspectum, LAN – L. borneensis. LAL – Lysosomal 
acid lipase, KLK – kallikrein.(Notice that positioning of exendin in HS might be an artefact, for it is a small 
peptide, though it is not unknown for the proteins to have modifications that would increase its MW almost 
tenfold). 
  
Figure 3. 1D PAGE non-reduced results. MER – V. mertensi, GIG – V. giganteus, RUB – V. panoptes 
rubidus, MIT – V. mitcheli, SCA – V. scalaris, TRI – V. tristis, GIL – V. gilleni, ACA – V. acanthurus, BAR – V. 
baritji. LAL – Lysosomal acid lipase, KLK – kallikrein. 
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Figure 4. 2D PAGE results. C  – CRiSP, L – Lysosomal acid lipase, K – kallikrein, HGF – Hepatocyte growth 
factor, A – AVIT, Ch – Chitotriosidase  
 
 
V. acanthurus 
V. gileni 
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Figure 5. 2D PAGE results. C  – CRiSP, L – Lysosomal acid lipase, K – kallikrein, HGF – Hepatocyte growth 
factor, A – AVIT, Ch – Chitotriosidase 
 
 
V. mertensi 
V. giganteus 
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V. p. rubidus V. mitchelli 
V. scalaris V. tristis 
Figure 6. 2D PAGE results.  
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  V. griseus V. prasinus 
V. jobiensis 
V. varius V salvadorii 
Figure 7. 2D PAGE results.  
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V. varius 
Figure 8. 17cm 2D PAGE results. C  – CRiSP, L – Lysosomal acid lipase, K – kallikrein, HGF – 
Hepatocyte growth factor, A – AVIT, Ch – Chitotriosidase, PLA2 – phsopholipase A2 type III 
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Figure 9. All components of varanoid oral secretion recovered in this study. 
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Bioactivity studies further strengthened the differences between the oral secretion profiles, 
with V. varius having the highest of all phospholipase A2 activity rate – almost three times 
higher than that of V. melinus and V. scalaris and an order of magnitude higher than the 
rest, most of which had no significant activity (fig. 10). No phospholipase A2 activity was 
recovered for V. mitchelli. Ability to cleave kallikrein substrate was equally variable 
between the species: V. mitchelli activity rate was more than twice than that of V. scalaris, 
V. panoptes rubidus, V. melinus and V. prasinus and almost ten-fold that of other species. 
V. gilleni and V. griseus had the least potency in that respect amongst all the species 
studied. 
The observed differences in activity rates, especially with respect to kallikrein, might be the 
consequence not only of the structural differences between the proteins of different 
species, but also a result of differential component complexity, as is clearly the case with 
V. mitchelli whose 2D profile is largely composed of different kallikrein isoforms. 
At the same time, differences in activity rate might be related to the dramatic size 
difference between the studied species – almost seven-fold between the smallest (V. 
gilleni) and biggest (V. varius) in SVL (snout to vent length). The prey-predator size ratio is 
drastically different for those species, and venom replenishment costs may also vary 
considerably. 
Experiments of the effect of V. varius venom on rat ileum contractility showed a 
pronounced effect of increased contractility induced by the administration of the crude 
venom (fig. 11). This may be attributable to the presence of AVIT and natriuretic peptides, 
as recovered by the MS analysis. 
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Figure 10. Normalised results of bioactivity testings. On the Y-axis is the initial activity rate normalised within 
the study group, with the highest rate being assign to 1 and the others calculated as a fraction of it. MIT – V. 
mitcheli, SCA – V. scalaris, TRI – V. tristis, ACA – V. acanthurus, GIL – V. gilleni, RUB – V. panoptes 
rubidus, GIG – V. giganteus, MER – V. mertensi, SAL – V. salvadorii, VAR – V. varius, MEL – V. melinus, 
JOB – V. jobiensis, PRA – V. prasinus, GRI – V. griseus. 
 
Figure 11. Change in rat ileum smooth muscle contractility after administration of crude V. varius venom.On 
the Y-axis is the pulling force in relative units; on the X-axis is time. 
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Figure 12. Phylogenetic relationships between the studied species (based on Ast, 2001) with SVL 
meassurments (based on Pianka and King, 2004) and main findings of the present study. 
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The higher complexity of the venom of large species of monitor, in comparison to their 
smaller congeners, may be explained by the broader dietary range in larger species, both 
of the adult animals and across the life history (see fig. 12 for reference on size and 
phylogenetic relationships). As dietary studies of the lace monitor show (Pascoe et al., 
2012), it has the broadest possible dietary range, feeding on everything from small 
invertebrates and eggs to medium-sized mammals, most-likely experiencing ontogenetic 
niche shifts, which further necessitate adaptations to different prey items. At the same time 
smaller species (members of the Odatria group) predominately feed on lizards and insects 
throughout their life (Pinka and King, 2004). 
The dietary connections seems especially clear with respect to the presence of chitinase 
and chitotriosidase in all the venoms of Odatria monitors (fig. 10) (with the sole exception 
of V. mitcheli) and the complete absence of these enzymes in monitors of other groups. 
Odatria or dwarf monitors are unique to Australia, presumably due to the absence of 
eutherian mammal carnivores. No member of the clade grows bigger than 600 mm SVL 
and most of them are exclusively arboreal or rock-dwelling. Chitinase enzymes are likely 
helpful in the digestion of thick carapaces of arthropods, which are their substantial food 
source. The potential digestive role of the varanid venom was previously set up as a 
hypothesis (Arbuckle, 2009) and our data seems to corroborate it. 
The greater complexity of the V. gilleni venom profile in comparison to other dwarf 
monitors might be reflective of a plesiotypic condition, since it is the most basal species in 
the study from that group and it probably did not undergo an evolutionary habitat shift from 
the putatively ancestral arboreal condition (Collar et al., 2011; Thompson et al., 2009) – 
the transition to a rock-dwelling lifestyle might be associated with the streamlining of the V. 
acanthurus and V. baritji venom profiles. 
Habitat might likewise be responsible for the relative simplicity of V. mitchelli and 
especially V. mertensi profiles, since both of the monitors are predominantly aquatic and 
might have both a reduced need for defensive venom due to their ability to seek refuge in 
water and a reduced need for predatory venoms due to a diet dominated by fish and 
aquatic arthropods. 
Since rock-dwelling may be the only lifestyle that imposes significant constraints on body 
shape – in particular on the shape of the head (Openshaw and Keogh, 2014; Thompson et 
al., 2009), it is possible that rock-dwelling monitors like V. acanthurus and V. baritji 
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experience increased selection pressure on the size and therefore function of their venom 
glands and have reduced venom complexity as a result. 
If that is indeed the case, then from the perspective of the evolution of oral secretion in 
varanids those species would represent the most remote state from the ancestral 
condition, having undergone firstly an adaptation to dwarfism (for instance in the form of 
chitin-digesting enzymes) and secondly an adaptation to rock-dwelling that purified 
secretion of all that was not essential. 
In this line of argument, the gouldii group would represent the venom system in its 
plesiotypic state for the Australasian monitors, retaining the kallikrein/CRiSP-dominated 
profile, which is not dissimilar from Indo-Asian species examined in this study. On the 
other hand, the varius group, which contains the lace monitor (V. varius), crocodile monitor 
(V. salvadorii) and Komodo dragon (V. komodoensis) has the most diverse venom with 
protein groups across the entire molecular-weight range, and is less rich in kallikrein and 
CRiSP than other clades. This might be explained as an adaptation to the large body size 
and increased dietary range and habitat shifts those lizards experience across their life 
histories. 
Amongst those studied, the V. griseus profile might reflect the most plesiotypic condition of 
varanid oral secretions in general, since it was the most basal species examined, although 
it should be noted that basal species are not necessarily the closest to ancestral states. Its 
oral secretion contains kallikrein, CRiSP, AVIT and lysosomal acid lipase, three of which 
are present in most of the venoms studied and all four are present in venoms of other non-
Australian monitors. However, none of those components are heavily expressed in the 
venom if 2D PAGE results are of any indication. If not a sampling artefact, that might be 
either reflective of the condition of the venom system that the ancestor common to V. 
griseus and other monitors had, or could reflect subsequent changes the system 
underwent through adaptation to desert life-style of this monitors.  
Conclusion 
The oral secretions of varanoid lizards represent a heavily understudied area. Multiple 
sources of evidence point to an ongoing evolutionary process shaping the secretion 
content that is very likely to be playing a crucial role in the lives of varanid lizards. The 
present study reveals the differential complexity of oral secretion in Varanus and argues 
for the evolutionary causes behind it. 
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According to our results, varanid venom is largely based on kallikrein and CRiSP toxins 
that previous studies have shown to be homologous to that of venomous snakes (Fry et 
al., 2010a). Additional components are present in various species with profile complexity 
seemingly being a function of size and habitat with the bigger arboreal species having the 
most complex venom and the small rock-dwelling and aquatic monitors the least. 
Some components recovered in the study are very likely to be an adaptation for arthropod-
based diet, which strengthens the point that venom glands in varanid lizards have more 
than a single function. That is, in addition to its potential role in prey subjugation or 
defence (the primary roles of any venom system), varanid lizards` oral secretion can 
potentially aid in digestion. 
With 16 varanid species studied out of more than 60 species in existence, this study is far 
from being an attempt to paint a complete picture of evolution of oral secretions in 
Varanus, and future studies are very likely to expand our knowledge on the topic. For 
example it will be very interesting to see the venom profile of V. salvator – a big, but 
predominantly aquatic lizard, as well as frugivorous species (such as Varanus olivaceus) 
from Indo-Asian A clade (classification according to Ast, 2001). 
It is abundantly clear that the unique nature of venom in varanid lizards presents 
interesting evolutionary questions that will require a systems approach to be solved in any 
satisfying way. Turning away from this fruitful area of research by denying the biochemical 
reality of their secretions will only hinder our progress. 
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Conclusions 
Anguimorpha venoms are diverse and reflect the variety of ecological niches occupied and 
feeding strategies implemented by these lizards. The current study provides insight into 
the evolutionary trajectories of defensive and predatory venoms that share a relatively 
recent common origin. 
Venoms of Heloderma lizards appear to have remained relatively uinchanged for more 
than 30 mya, their proteomic composition showing no difference between the individuals 
from different localities or members of different species. Several major helodermatid toxin 
genes appear to be under the heavy influence of negative selection. 
At the same time varanid lizards have evolved a plethora of different venom profiles, some 
of which are extremely streamlined while others are remarkably complex, in particular that 
of the Varius clade, which may be tailored to suit their ontogenetic niche shift. Some of the 
components of monitor oral secretions suggest that venom in varanids serve several 
purposes. Most notably, chitinase, present in small monitors of Odatria clade, hints that 
venom might aid in digestion as well as being used in defence or prey subjugation. 
Altogether our findings suggest a great role that habitat and diet play in evolution of venom 
composition. Though it is very hard to discern the environmental effect from purely 
phylogenetic one, juxtaposing Heloderma (no environment or venom diversity across the 
genus) and Varanus (great diversity both in environment and venom across the genus), as 
well as comparing different species within Varanus (despite belonging to different clades, 
both aquatic monitors V. mertensi and V. mitcheli have streamlined venom profiles) allow 
for potential insight on the forces that shaped venoms in reptiles. 
The present study also highlights the importance of biodiscovery research being driven by 
advances in phylogenetics as well as the cost of biased conceptions about nature. There 
are more than 50 described species of varanid lizard, of which only 16 have had their 
venom investigated, with most of that only over the course of this study. African varanids 
are completely unstudied in this respect and, judging by the venom complexity of their 
Australian counterparts, there is incredible potential for further research out there. Reality 
will always outperform our expectations, which is why we should always prefer to study 
nature before making assumptions about it. 
